{
  "meta": {
    "title": "00011_Late_Night_Pyq_Pyt_Marathon_-_11",
    "url": "https://brainandscalpel.vercel.app/00011-late-night-pyq-pyt-marathon-11-ae61e3f5.html",
    "scrapedAt": "2025-11-29T17:24:28.923Z"
  },
  "questions": [
    {
      "id": 54891,
      "choices": [
        {
          "id": 219025,
          "text": "<p><span style=\"font-size:12.0pt;\">Phacolytic glaucoma</span></p>"
        },
        {
          "id": 219026,
          "text": "<p><span style=\"font-size:12.0pt;\">Malignant glaucoma</span></p>"
        },
        {
          "id": 219027,
          "text": "<p><span style=\"font-size:12.0pt;\">Fuch heterochromic iridocyclitis</span></p>"
        },
        {
          "id": 219028,
          "text": "<p><span style=\"font-size:12.0pt;\">Phacomorphic glaucoma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 80 year old male presented with diminution of vision since 2 years. The right eye was red and painful. On examination, the IOP was 50 mmHg in right eye and 16 mmHg in left eye. The right eye had deep anterior chamber with some cells and flare. What could be the possibility? (INICET MAY 2024)</span></p>",
      "unique_key": "Q5457997",
      "question_audio": null,
      "question_video": null,
      "map_id": 11999544,
      "difficulty_level": "beginner",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Phacolytic glaucoma</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Phacolytic glaucoma is characterized by the leakage of lens proteins through an intact lens capsule, which causes an inflammatory response in the eye. This condition often occurs in elderly patients with hypermature cataracts. The leakage of proteins results in cells and flare in the anterior chamber, as well as a deep anterior chamber. The clinical presentation described in the question, including the deep anterior chamber with cells and flare and the patient's age, aligns with the characteristics of phacolytic glaucoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Malignant glaucoma</strong>: Malignant glaucoma, also known as aqueous misdirection syndrome, is characterized by a shallow anterior chamber and elevated intraocular pressure (IOP). This condition typically does not present with cells and flare in the anterior chamber, making it an unlikely diagnosis in this case.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Fuch heterochromic iridocyclitis</strong>: Fuch heterochromic iridocyclitis usually presents in younger patients, and it is less likely to occur in an 80-year-old individual. This condition is characterized by heterochromia (difference in eye color) and mild anterior uveitis, but it does not typically present with the deep anterior chamber and the level of inflammation described in the question.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Phacomorphic glaucoma</strong>: Phacomorphic glaucoma occurs due to the swelling of a mature cataract, which leads to a shallow anterior chamber and increased IOP. The question describes a deep anterior chamber, which is not consistent with phacomorphic glaucoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Phacolytic glaucoma presents with a deep anterior chamber, cells and flare due to leakage of lens proteins, and typically occurs in elderly patients with hypermature cataracts.</span></p>",
      "correct_choice_id": 219025,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 56079,
      "choices": [
        {
          "id": 223741,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">30.5 mg</span></span></span></p>"
        },
        {
          "id": 223742,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">45 mg</span></span></span></p>"
        },
        {
          "id": 223743,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">20 mg</span></span></span></p>"
        },
        {
          "id": 223744,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">60 mg</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A 40-year-old man with a history of hypertension and hyperlipidemia is admitted to the hospital for the management of a new medication to control his chronic condition. As part of his treatment, he receives a single 200 mg dose of a drug that follows first-order kinetics. After 90 minutes, it is noted that 75 mg of the drug has been excreted. The patient&rsquo;s pharmacokinetic profile is being evaluated to determine the appropriate dosing schedule. Six hours after the initial dose, blood tests are conducted to assess how much of the drug remains in his system. What is the expected amount of the drug remaining in the body after 6 hours?</span></span></span></p>",
      "unique_key": "Q5008737",
      "question_audio": null,
      "question_video": null,
      "map_id": 11999875,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<h3><span style=\"font-size:14pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"color:#434343\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ans. </span></span></span></strong><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A. 30.5 mg</span></span></strong></span></span></span></h3>\r\n\r\n<h3>&nbsp;</h3>\r\n\r\n<h3><span style=\"font-size:14pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"color:#434343\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Explanation:</span></span></span></strong></span></span></span></h3>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">To solve this question, we use the formula for first-order kinetics to determine the elimination rate constant (k) and calculate the amount of drug remaining after 6 hours:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">First, determine the elimination rate constant (k):</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">k = {log (C0/Ct)} / t​</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Where:</span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">C₀ = initial concentration (200 mg)</span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Cₜ = concentration after time t (125 mg, since 200 mg - 75 mg = 125 mg after 1.5 hours)</span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">t = time in hours (1.5 hours)</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Calculating k:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">k={log</span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Cambria Math&quot;,serif\">⁡</span></span><span style=\"font-size:12.0pt\">(1.6)} / 1.5</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">k &asymp; 0.470/1.5</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">k &asymp; 0.313 hr<sup>&minus;1</sup></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Next, calculate the half-life using the relationship between k and t₁/₂:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">t1/2 = 0.693 /k</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">t1/2 ​= 0.693​/0.313</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">t1/2 = 2.21 hours</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Now, use the first-order kinetics formula to determine the amount of drug left after 6 hours:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ct = 200 &times; e</span><sup><span style=\"font-size:12.0pt\">&minus;0.313&times;6</span></sup></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ct = 200 &times; e</span><sup><span style=\"font-size:12.0pt\">&minus;1.878</span></sup></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ct = 200 &times; 0.153</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ct &asymp; 30.5 mg</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<h3><span style=\"font-size:14pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"color:#434343\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Educational Objective:</span></span></span></strong></span></span></span></h3>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In first-order kinetics, the rate of elimination is proportional to the concentration of the drug. Using the elimination rate constant and half-life, clinicians can accurately predict how much drug remains in the body, ensuring effective and safe dosing adjustments.</span></span></span></p>",
      "correct_choice_id": 223741,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10251,
      "choices": [
        {
          "id": 40970,
          "text": "<p><span style=\"font-size:18px;\">1, 2, 3, 4</span></p>"
        },
        {
          "id": 40971,
          "text": "<p><span style=\"font-size:18px;\">2, 3, 4</span></p>"
        },
        {
          "id": 40972,
          "text": "<p><span style=\"font-size:18px;\">1, 2, 3</span></p>"
        },
        {
          "id": 40973,
          "text": "<p><span style=\"font-size:18px;\">1, 2, 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\"><strong>You are employed at a primary health center (PHC) located in an area with a high risk of earthquakes. What actions would you take to ensure readiness for potential emergencies? </strong><i><strong>[NEET PG 2022]</strong></i></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:18px;\"><strong>Disaster preparedness by making sure all financial and other resources are available</strong></span></li><li><span style=\"font-size:18px;\"><strong>Increase public awareness through campaigns and loudspeakers</strong></span></li><li><span style=\"font-size:18px;\"><strong>Conduct a simulation for the disaster and assess the response</strong></span></li><li><span style=\"font-size:18px;\"><strong>Follow instructions given over the phone or radio by higher officials</strong></span></li></ol>",
      "unique_key": "Q3462093",
      "question_audio": null,
      "question_video": null,
      "map_id": 11999976,
      "difficulty_level": "intermediate",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (c) 1,2,3</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">To ensure readiness for potential emergencies in a high-risk earthquake area, the following actions are crucial:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:18px;\"><strong>Disaster Preparedness:</strong> Ensuring all financial and other resources are available. This involves mobilizing funds and resources for quick evacuation and emergency response.</span></li><li><span style=\"font-size:18px;\"><strong>Increase Public Awareness:</strong> Conducting campaigns and using loudspeakers to inform the public about earthquake preparedness measures and safety protocols.</span></li><li><span style=\"font-size:18px;\"><strong>Conduct a Simulation:</strong> Performing disaster simulations and assessing the response to identify areas for improvement and ensure the effectiveness of the emergency plan.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:18px;\">These steps are essential components of a comprehensive disaster preparedness strategy and done by someone working in a PHC situated in a high seismic zone. A medical officer is supposed to provide instructions by any communication method possible to manage through the calamity.</span></p><p>&nbsp;</p><h3><span style=\"color:black;font-size:18px;\"><strong>Roles and responsibilities of medical officer of PHC when posted in Seismic areas</strong></span></h3><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:18px;\">Ensure funds and resources are available and can be mobilized at the time of disaster for quick evacuation</span></li><li><span style=\"font-size:18px;\">Preparedness to handle emergency</span></li><li><span style=\"font-size:18px;\">Disaster simulation practices and then check the response</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">While following instructions from higher officials is important during an actual disaster, it is not a proactive preparedness measure.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Emergency preparedness is a programme of long-term development activities whose goals are to strengthen the overall capacity and capability of a country to manage efficiently all types of emergency. It involves the following steps:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:18px;\">Disaster preparedness by making sure all financial and other resources are available</span></li><li><span style=\"font-size:18px;\">Increase public awareness through campaigns and loudspeakers</span></li><li><span style=\"font-size:18px;\">Conduct a simulation for the disaster and assess the response</span></li><li><span style=\"font-size:18px;\">Evaluate the risk of disaster</span></li><li><span style=\"font-size:18px;\">Information sessions coordination with news media</span></li><li><span style=\"font-size:18px;\">Adopt standards and regulations</span></li></ol>",
      "correct_choice_id": 40972,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9932,
      "choices": [
        {
          "id": 39694,
          "text": "<p><span style=\"font-size:12pt;\">Psoriasis vulgaris</span></p>"
        },
        {
          "id": 39695,
          "text": "<p><span style=\"font-size:12pt;\">Leishmaniasis</span></p>"
        },
        {
          "id": 39696,
          "text": "<p><span style=\"font-size:12pt;\">Mycosis fungoides</span></p>"
        },
        {
          "id": 39697,
          "text": "<p><span style=\"font-size:12pt;\">Pemphigus vulgaris</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">The histopathology picture below is suggestive of? (AIIMS NOV 2017)</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/19/untitled-13496.jpg\" alt=\"\" width=\"300\" height=\"217\"></p>",
      "unique_key": "Q8832810",
      "question_audio": null,
      "question_video": null,
      "map_id": 11999977,
      "difficulty_level": "beginner",
      "subjects_id": [
        18
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) Pemphigus vulgaris</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">The given slide shows a <strong>row of tombstones' appearance</strong>, which is classically seen in Pemphigus vulgaris.</span></li><li><span style=\"font-size:12pt;\">The production of <strong>antibodies, specifically those against Desmoglein 3</strong>, is seen in Pemphigus vulgaris.</span></li><li><span style=\"font-size:12pt;\"><strong>Desmoglein 1&nbsp;</strong>antibodies are also occasionally associated.</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/27/picture29.jpg\" alt=\"\" width=\"600\" height=\"559\"></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Usually, the antibodies are <strong>IgG antibodies</strong>. The skin and mucosa's <strong>basal and suprabasal</strong> layers contain the majority of <strong>Desmoglein 3</strong>.</span></li><li><span style=\"font-size:12pt;\"><strong>Hemidesmosomes&nbsp;</strong>help in connecting <strong>basal layer </strong>to underlying <strong>dermo-epidermal junction</strong>, in <strong>pemphigus vulgaris</strong> there are <strong>no antibodies</strong> against <strong>Hemidesmosomes</strong>, so the basal layer remains attached to the underlying dermo-epidermal junction giving the classical <strong>Row of tombstones appearance</strong>.</span></li><li><span style=\"font-size:12pt;\">The patients, therefore, present with <strong>flaccid bullae over the skin</strong> and due to Desmoglein 3 involvement, mucosal involvement can also be seen.</span></li><li><span style=\"font-size:12pt;\"><strong>Oral mucosa is commonly affected</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/27/picture30.jpg\" alt=\"\" width=\"400\" height=\"266\"></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Other areas where ulceration can be seen are <strong>conjunctiva</strong>, <strong>nasopharynx, larynx</strong>, etc.</span></li><li><span style=\"font-size:12pt;\">Cutaneous lesions are more common over the <strong>scalp, face, neck, upper chest, and back as seen in the image below.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><i><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/27/picture31.jpg\" alt=\"\" width=\"400\" height=\"302\"></strong></i></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Biopsy:&nbsp;</strong>The basal layer remains adherent to the basement membrane and gives the resemblance to a <strong>row of tombstones.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/19/untitled-13497.jpg\" alt=\"\" width=\"600\" height=\"214\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">IMAGE of row of tombstones appearance.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Psoriasis vulgaris:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">This is an <strong>autoimmune</strong> disease characterized by <strong>hyperproliferation of keratinocytes</strong> leading to thickened, <strong>scaly plaques</strong>.</span></li><li><span style=\"font-size:12pt;\">Histologically, it shows <strong>parakeratosis</strong> (<strong>retention of nuclei </strong>in the stratum c<strong>orneum</strong>), elongation of <strong>rete ridges</strong>, and a <strong>neutrophilic </strong>infiltrate (<strong>Munro's </strong>microabscesses) as shown in the image below.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/27/picture32.jpg\" alt=\"\" width=\"400\" height=\"178\"></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">The tombstone appearance is not a feature of psoriasis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Leishmaniasis:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">It's a <strong>parasitic</strong> infection caused by the <strong>Leishmania</strong> species.</span></li><li><span style=\"font-size:12pt;\">Histologically, it is characterized by <strong>macrophages</strong> containing the <strong>parasite</strong> <strong>(Leishman-Donovan bodies</strong>) in the <strong>dermis </strong>as shown in the image below.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/27/picture33.jpg\" alt=\"\" width=\"400\" height=\"398\"></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">The tombstone appearance is not seen in leishmaniasis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Mycosis fungoides:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">This is a type of <strong>cutaneous T-cell lymphoma</strong>.</span></li><li><span style=\"font-size:12pt;\">Histologically, there is an <strong>atypical lymphocytic </strong>infiltrate in the epidermis <strong>(epidermotropism</strong>), and the formation of <strong>Pautrier's microabscesses </strong>(collections of l<strong>ymphocytes</strong> in the epidermis) as shown in the image below.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/27/picture34.jpg\" alt=\"\" width=\"400\" height=\"227\"></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">It does <strong>not</strong> exhibit a <strong>tombstone appearance</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/27/screenshot-2023-11-27-180630.jpg\" alt=\"\" width=\"1000\" height=\"596\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The histopathology image suggests <strong>Pemphigus vulgaris</strong>, which is characterized by <strong>intraepidermal blistering</strong> due to <strong>acantholysis</strong>, or <strong>separation of keratinocytes</strong>, as a result of <strong>autoantibody</strong> attack on <strong>desmosomal proteins.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref - Rook's Textbook of Dermatology - 9th Edition Chapter 50 Page no 50.1</strong></span></p><p><span style=\"font-size:12pt;\"><strong>Robbins &amp; cotran Pathologic Basis of disease 10e- page no 1160</strong></span></p>",
      "correct_choice_id": 39697,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 23234,
      "choices": [
        {
          "id": 92900,
          "text": "<p><span style=\"font-size:12.0pt;\">3 and 4</span></p>"
        },
        {
          "id": 92901,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2 and 3</span></p>"
        },
        {
          "id": 92902,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 3 and 4</span></p>"
        },
        {
          "id": 92903,
          "text": "<p><span style=\"font-size:12.0pt;\">2, 3 and 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What are the components of Nada's Minor Criteria? (INICET MAY 2023)</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Systolic mumur Grade 3</span></li><li><span style=\"font-size:12.0pt;\">Diastolic murmur</span></li><li><span style=\"font-size:12.0pt;\">Abnormal second heart sound</span></li><li><span style=\"font-size:12.0pt;\">Abnormal BP</span></li></ol>",
      "unique_key": "Q2099172",
      "question_audio": null,
      "question_video": null,
      "map_id": 11999978,
      "difficulty_level": "intermediate",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) 3 and 4</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Nada’s criteria is used for detection of CHD on the basis of clinical evaluation.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/18/screenshot-2024-09-18-151020.png\" alt=\"\" width=\"1000\" height=\"287\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Presence of 1 major or 2 minor criteria suggest presence of heart disease.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span><br>&nbsp;</p><p><span style=\"font-size:12pt;\">In Nada’s criteria for detecting congenital heart disease, minor criteria include an abnormal second heart sound and abnormal blood pressure. The presence of one major or two minor criteria suggests the presence of heart disease.</span></p>",
      "correct_choice_id": 92900,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7488,
      "choices": [
        {
          "id": 29920,
          "text": "<p><span style=\"font-size:12pt;\">Furuncle</span></p>"
        },
        {
          "id": 29921,
          "text": "<p><span style=\"font-size:12pt;\">Epidermoid cyst</span></p>"
        },
        {
          "id": 29922,
          "text": "<p><span style=\"font-size:12pt;\">Kerion</span></p>"
        },
        {
          "id": 29923,
          "text": "<p><span style=\"font-size:12.0pt;\">Folliculitis</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 10-year-old male child complains of mild painful swelling over the scalp for 3 months as shown in the image below. He also has a pet dog at his home. What is the diagnosis of the given condition? (NEET PG 2021)</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/06/460.jpg\" alt=\"\" width=\"300\" height=\"253\"></span></p>",
      "unique_key": "Q4276244",
      "question_audio": null,
      "question_video": null,
      "map_id": 11999979,
      "difficulty_level": "beginner",
      "subjects_id": [
        18
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C. Kerion</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The case of a young boy coming into contact with a <strong>zoophilic organism</strong> and displaying symptoms of a <strong>boggy inflammatory</strong> mass, accompanied by thick <strong>crusting and matting</strong> of hair, indicates a possible diagnosis of kerion.</span></li><li><span style=\"font-size:12.0pt;\">Kerion is an intense <strong>inflammatory </strong>form of tinea capitis, caused by dermatophytes that have an affinity for animals (<strong>pet dog clue).</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Tinea capitis variants:</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/15/screenshot-2024-06-15-104534.png\" alt=\"\" width=\"900\" height=\"99\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/15/screenshot-2024-06-15-104603_tmoEqmt.png\" alt=\"\" width=\"900\" height=\"384\"></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Kerion:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/17/untitled-1337.jpg\" alt=\"\" width=\"300\" height=\"253\"></strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Lesion:</strong> Boggy indurated scalp swelling</span></li><li><span style=\"font-size:12.0pt;\">Easily pluckable hair associated with regional lymphadenopathy</span></li><li><span style=\"font-size:12.0pt;\"><strong>Most common causative organisms</strong> - T. verrucosum and T. mentagrophytes.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Investigation:</strong> 10% KOH mount</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Treatment:</strong> DOC overall and for Microsporum à <strong>Griseofulvin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Note: </strong>DOC for Trichophyton à <strong>Terbinafine.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Furuncle:</strong></span></p><ul><li><span style=\"font-size:12.0pt;\"><strong>Description: Also known as a boil,</strong> a <strong>furuncle is a deep folliculitis</strong>, an infection of the hair follicle.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Reason for exclusion from the diagnosis:</strong> Furuncles are typically <strong>more localized</strong> and painful and would not be described as \"boggy.\" Also, they <strong>don’t have a direct association</strong> with having a <strong>pet dog</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Epidermoid cyst:</strong></span></p><ul><li><span style=\"font-size:12.0pt;\">Description: These are benign cysts <strong>originating from the epidermis</strong>. They are filled with <strong>keratin </strong>and have a characteristic <strong>central punctum as seen in the image below</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/28/screenshot-2023-09-28-125009.jpg\" alt=\"\" width=\"400\" height=\"176\"></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Reason for exclusion from the diagnosis:</strong> Epidermoid cysts are typically <strong>non-painful unless infected. </strong>They do not usually present as <strong>boggy swellings</strong> and are <strong>not</strong> related to having a <strong>pet.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Folliculitis:</strong></span></p><ul><li><span style=\"font-size:12.0pt;\">Description: Folliculitis is the <strong>inflammation or infection</strong> of one or more hair follicles.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Reason for exclusion from the diagnosis:</strong> Folliculitis on the scalp would typically present as <strong>multiple small, itchy, and red pustules</strong>. It wouldn't create a boggy swelling as described in the question.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Kerion</strong> is a <strong>boggy,</strong> tender <strong>scalp swelling </strong>associated with <strong>hair loss </strong>and potentially linked to animal exposure, indicative of a f<strong>ungal</strong> infection rather than a bacterial cause like furuncle or folliculitis, or a benign lesion such as an epidermoid cyst.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Rook's Textbook of Dermatology 9th Edition Page no 26.22, 26.23-26.24, 32.38, 32.39, 32.40, 90.27, 108.11</strong></span></p>",
      "correct_choice_id": 29922,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13989,
      "choices": [
        {
          "id": 55917,
          "text": "<p><span style=\"font-size:12.0pt;\">Cardiac tamponade</span></p>"
        },
        {
          "id": 55918,
          "text": "<p><span style=\"font-size:12.0pt;\">Tension pneumothorax</span></p>"
        },
        {
          "id": 55919,
          "text": "<p><span style=\"font-size:12.0pt;\">Pericardial effusion</span></p>"
        },
        {
          "id": 55920,
          "text": "<p><span style=\"font-size:12.0pt;\">Massive hemothorax</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 40-year-old female victim of RTA presents to the ER. On examination, GCS is 15/15, heart rate = 110/min, BP = 90/60 mmHg, and there is elevated JVP. The right chest is tympanic on percussion with decreased breath sounds on auscultation. The left chest appears normal. But the patient is dyspneic and ecchymosis is noted over the chest wall. The abdomen is soft. The probable diagnosis is: (AIIMS MAY 2018)</span></p>",
      "unique_key": "Q2782176",
      "question_audio": null,
      "question_video": null,
      "map_id": 11999980,
      "difficulty_level": "beginner",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Tension Pneumothorax</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The given clinical scenario of hemodynamic instability, tympanic note (hyper-resonant) on percussion, and decreased breath sounds on the affected side is suggestive of tension pneumothorax.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Tension pneumothorax occurs when air accumulates in the pleural space and cannot escape, leading to increased pressure in the chest cavity. This condition can compress the lungs and the great vessels in the chest, causing respiratory distress, hypotension, elevated JVP, and decreased breath sounds on auscultation. Tympanic percussion note over the right chest is consistent with air in the pleural space. Ecchymosis (bruising) over the chest wall can result from trauma and rib fractures associated with tension pneumothorax.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Cardiac tamponade</strong>: Cardiac tamponade typically presents with symptoms such as hypotension, muffled heart sounds, and distended neck veins (Jugular Venous Pressure - JVP). While elevated JVP is mentioned in the scenario, the other symptoms associated with cardiac tamponade, such as muffled heart sounds and hypotension, are not present.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Pericardial effusion</strong>: Pericardial effusion involves the accumulation of fluid around the heart. While it can cause elevated JVP, it typically presents with other cardiac symptoms, such as muffled heart sounds and chest pain. The scenario does not mention these cardiac-specific symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Massive hemothorax</strong>: Massive hemothorax refers to a significant accumulation of blood in the pleural space. It can cause decreased breath sounds, but it is not typically associated with a tympanic percussion note or elevated JVP unless there is concurrent tension pneumothorax.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A tension pneumothorax develops when there is a tear is either in the parietal or visceral pleura. This tear acts as a one-way valve i.e., air enters from the lung or chest wall through it during inspiration but has no way to escape during expiration. This ultimately causes collapse of the affected lung.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>It is characterized by:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Chest pain</span></li><li><span style=\"font-size:12.0pt;\">Tachypnoea, and acute dyspnea</span></li><li><span style=\"font-size:12.0pt;\">Sudden onset hemodynamic compromise (tachycardia, hypotension, low O2 saturation, loss of consciousness)</span></li><li><span style=\"font-size:12.0pt;\">Neck vein distention</span></li><li><span style=\"font-size:12.0pt;\">Tracheal deviation away from the side of injury</span></li><li><span style=\"font-size:12.0pt;\">Decreased chest movements on the affected side</span></li><li><span style=\"font-size:12.0pt;\">Hyper-resonance on percussion on the affected side</span></li><li><span style=\"font-size:12.0pt;\">Absence or decreased breath sounds on the affected side</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Tension pneumothorax is a clinical diagnosis, and treatment must never be delayed waiting for radiological confirmation. Management includes:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Immediate management:&nbsp;</strong>Needle decompression or needle thoracostomy i.e. insertion of a wide-bore needle in the 5th ICS anterior to the midaxillary line. In the pediatric age group, the needle thoracostomy location is at the 2nd ICS midclavicular line.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Definitive management:&nbsp;</strong>Tube thoracostomy or chest tube insertion in the 5th ICS in the triangle of safety.</span></li></ul>",
      "correct_choice_id": 55918,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 43945,
      "choices": [
        {
          "id": 175443,
          "text": "<p><span style=\"font-size:12.0pt;\">Seminoma</span></p>"
        },
        {
          "id": 175444,
          "text": "<p><span style=\"font-size:12.0pt;\">Yolk sac tumor</span></p>"
        },
        {
          "id": 175445,
          "text": "<p><span style=\"font-size:12.0pt;\">Leydig cell tumor</span></p>"
        },
        {
          "id": 175446,
          "text": "<p><span style=\"font-size:12.0pt;\">Sertoli cell tumor</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Reinke crystals are seen in which of the following gonadal tumours: (INICET NOV 2023)</span></p>",
      "unique_key": "Q6749667",
      "question_audio": null,
      "question_video": null,
      "map_id": 11999981,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Leydig cell tumor</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Reinke crystals are a specific and distinguishing feature of Leydig cell tumors. These crystals are eosinophilic, rod-shaped, crystalline inclusions found in the cytoplasm of Leydig cells. Leydig cell tumors are non-germ cell, sex cord-stromal tumors of the testicles that are typically benign.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Seminoma:&nbsp;</strong>Does not feature Reinke crystals; characterized by uniform cells with clear cytoplasm and central nuclei, often associated with lymphocytic infiltration.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Yolk sac Tumor</strong>: Lacks Reinke crystals; known for Schiller-Duval bodies and a pattern resembling endodermal sinus structures.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Sertoli cell Tumor</strong>: Also does not contain Reinke crystals; these tumors may show tubular or trabecular growth patterns and are often clinically silent.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Reinke crystals are pathognomonic of Leydig cell tumors of the testis and are useful in differentiating these from other testicular neoplasms.</span></p>",
      "correct_choice_id": 175445,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10362,
      "choices": [
        {
          "id": 41414,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Relaxation of lower esophageal sphincter</span></span></span></p>"
        },
        {
          "id": 41415,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Defective peristalsis</span></span></span></p>"
        },
        {
          "id": 41416,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Decreased release of NO and VIP in the distal part of esophagus</span></span></span></p>"
        },
        {
          "id": 41417,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Decreased tone of the lower esophageal sphincter</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following statements is true about the pathology of achalasia cardia? (NEET PG 2020)</span></span></p>",
      "unique_key": "Q1834051",
      "question_audio": null,
      "question_video": null,
      "map_id": 11999982,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) Decreased release of NO and VIP in the distal part of esophagus&nbsp; </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Achalasia cardia is characterized by decreased release of NO and VIP in the distal part of esophagus.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The LES relaxes during swallowing due to the release of nitric oxide and vasoactive intestinal polypeptide from inhibitory neurons, as well as the interruption of normal cholinergic signaling. These inhibitory neurons degenerate in achalasia cardia, resulting in decreased NO and VIP release. This results in increased LES tone.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Relaxation of lower esophageal sphincter:&nbsp;</span></strong><span style=\"font-size:12.0pt\">This is incorrect. In achalasia cardia, there is incomplete relaxation of the LES, not relaxation.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Defective peristalsis:&nbsp;</span></strong><span style=\"font-size:12.0pt\">While this statement is related to achalasia cardia, it is not the most accurate or complete description of the pathology. The correct answer focuses specifically on the decreased release of NO and VIP, which directly explains the increased LES tone and subsequent symptoms.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Decreased tone of the lower esophageal sphincter:&nbsp;</span></strong><span style=\"font-size:12.0pt\">This is incorrect. In achalasia cardia, the tone of the LES is increased, not decreased.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The triad of achalasia cardia</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> <strong>is as follows:</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ol>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Incomplete relaxation of LES</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Increased tone of LES</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Absent peristalsis (aperistalsis)</span></span></span></li>\r\n</ol>",
      "correct_choice_id": 41416,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6006,
      "choices": [
        {
          "id": 23994,
          "text": "<p><span style=\"font-size:12pt;\">Elective C-section has no role in reducing incidence of brachial plexus injury</span></p>"
        },
        {
          "id": 23995,
          "text": "<p><span style=\"font-size:12pt;\">In a patient being planned for induction of labor, night dose of intermediate insulin is given as planned, and the morning dose is withheld</span></p>"
        },
        {
          "id": 23996,
          "text": "<p><span style=\"font-size:12pt;\">In active labor, if RBS &lt;70 mg%, D5 is started at 100-150 ml/h till the RBS is &gt;100 mg%</span></p>"
        },
        {
          "id": 23997,
          "text": "<p><span style=\"font-size:12pt;\">Capillary blood glucose monitoring levels are kept at fasting- 95 mg%; 1 h postprandial- 140 mg%; 2 h postprandial: 120 mg%</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is false regarding management of diabetes in pregnancy?&nbsp;</span>(INICET MAY 2022)</p>",
      "unique_key": "Q6509098",
      "question_audio": null,
      "question_video": null,
      "map_id": 12000004,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Elective C-section has no role in reducing incidence of brachial plexus injury</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">False statement regarding management of diabetes in pregnancy is option A.</span></li><li><span style=\"font-size:12pt;\">The Cesarean section is found to be protective against traumatic injuries such as brachial plexus injury, in macrosomic babies born to mothers with diabetes.</span></li><li><span style=\"font-size:12pt;\">Elective LSCS is recommended when the estimated fetal weight is &gt; 4.5kg in diabetic mothers to reduce the incidence of birth trauma</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. In a patient being planned for induction of labor, night dose of intermediate insulin is given as planned, and the morning dose is withheld</strong>: In a planned delivery, although the bedtime dose of intermediate-acting insulin is given, it is recommended that the morning dose must be withheld</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Insulin Management for Labor Induction or Scheduled Cesarean Delivery</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/27/untitled-236.jpg\" alt=\"\" width=\"900\" height=\"271\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. In active labor, if RBS &lt;70 mg%, D5 is started at 100-150 ml/h till the RBS is &gt;100 mg%:</strong> In active labor, if RBS (Random blood glucose) &lt;70 mg%, D5 (5% dextrose) is started at 100-150 ml/h till the RBS is &gt;100 mg%. Before initiation of labor, normal saline is used for iv infusion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Capillary blood glucose monitoring levels are kept at fasting- 95 mg%; 1 h postprandial- 140 mg%; 2 h postprandial: 120 mg%:</strong> Self-monitoring of capillary blood glucose is advised in a pregnant woman diagnosed with diabetes. The glucose goals recommended are:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Fasting: 95 mg/dL</strong></span></li><li><span style=\"font-size:12pt;\"><strong>1 h postprandial: 140 mg/dL</strong></span></li><li><span style=\"font-size:12pt;\"><strong>2 h postprandial: 120 mg/dL</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Elective C-section can reduce the incidence of brachial plexus injury in pregnancies complicated by diabetes, especially in cases of fetal macrosomia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 2807, Williams Obstetrics 26<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 23994,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13718,
      "choices": [
        {
          "id": 54833,
          "text": "<p><span style=\"font-size:12.0pt;\">Atlanto-occipital</span></p>"
        },
        {
          "id": 54834,
          "text": "<p><span style=\"font-size:12.0pt;\">Atlanto-axial</span></p>"
        },
        {
          "id": 54835,
          "text": "<p><span style=\"font-size:12.0pt;\">C2-C3</span></p>"
        },
        {
          "id": 54836,
          "text": "<p><span style=\"font-size:12.0pt;\">C3-C4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which joint allows for the side-to-side movement of the head, enabling a person to look to the right and left?(NEET PG 2019)</span></p>",
      "unique_key": "Q2078011",
      "question_audio": null,
      "question_video": null,
      "map_id": 12000005,
      "difficulty_level": "beginner",
      "subjects_id": [
        3
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Atlanto-axial</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The movements at the atlanto-axial joint allow a person to look left and right.</span></li><li><span style=\"font-size:12.0pt;\">The atlanto-axial joints consist of two lateral joints located on either side between the bottom of the atlas bone and the top of the axis bone, which are flat joints.</span></li><li><span style=\"font-size:12.0pt;\">Additionally, there is a central joint between the dens (a protrusion from the axis bone) and the front arch and transverse ligament of the atlas, which is a pivot joint.</span></li><li><span style=\"font-size:12.0pt;\">This central joint has two distinct synovial cavities - one in the front and one in the back.</span></li><li><span style=\"font-size:12.0pt;\">Rotatory movements occur at all three joints and revolve around a vertical axis.</span></li><li><span style=\"font-size:12.0pt;\">The dens acts as a pivot around which the atlas rotates (carrying the skull with it), allowing the head to rotate side to side.</span></li><li><span style=\"font-size:12.0pt;\">The alar ligaments restrict movement. Atlanto-axial rotation has a normal range of about 40°.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Atlanto-Axial joint</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/04/untitled-896.jpg\" alt=\"\" width=\"500\" height=\"316\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Atlanto-occipital joint</strong>: This joint is formed between the first cervical vertebra (the atlas or C1) and the occipital bone of the skull. It primarily permits the \"nodding\" motion of the head, as in signaling \"yes\". This joint allows for flexion and extension of the head, but not significant rotation. It's the joint that lets you tilt your head upward or downward.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>C2-C3 joint</strong>: This joint is between the second and third cervical vertebrae. While it does allow for some degree of rotation, it does not provide the primary rotational movement to look right or left. The range of motion at this joint is less compared to the atlanto-axial joint, and it's more involved in flexion, extension, and some lateral bending.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>C3-C4 joint</strong>: This joint is between the third and fourth cervical vertebrae. Like the C2-C3 joint, the C3-C4 joint also provides some degree of rotation but not the primary movement. Its main movements are flexion, extension, and lateral bending of the neck. The lower down the cervical spine you go, the less rotational capacity there typically is at each subsequent joint.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Atlanto-axial joint</strong> is formed between the first cervical vertebra (the atlas or C1) and the second cervical vertebra (the axis or C2). The dens or odontoid process, fits into the atlas, allowing for a pivot-like rotation. This is the joint responsible for allowing the rotation of the head from side to side, as in signaling \"no\" or looking right and left. It provides the majority of the rotational capability of the head.</span></p>",
      "correct_choice_id": 54834,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14046,
      "choices": [
        {
          "id": 56145,
          "text": "<p><span style=\"font-size:12.0pt;\">Total Thyroidectomy</span></p>"
        },
        {
          "id": 56146,
          "text": "<p><span style=\"font-size:12.0pt;\">Total Thyroidectomy plus Lymph node dissection</span></p>"
        },
        {
          "id": 56147,
          "text": "<p><span style=\"font-size:12.0pt;\">Radioiodine ablation of thyroid</span></p>"
        },
        {
          "id": 56148,
          "text": "<p><span style=\"font-size:12.0pt;\">Right Hemithyroidectomy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 25-year-old pregnant woman came with a history of thyroid swelling. FNAC was done and the report was suggestive of papillary carcinoma thyroid. The nodule was \"cold\" on scan. Which of the following will not be a treatment option for her? (AIIMS NOV 2017)</span></p>",
      "unique_key": "Q7334334",
      "question_audio": null,
      "question_video": null,
      "map_id": 12000006,
      "difficulty_level": "intermediate",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Radioiodine ablation of thyroid</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Radioiodine ablation is typically used after thyroidectomy to eliminate any remaining thyroid tissue and residual cancer cells. However, it is contraindicated during pregnancy due to the risk of harm to the developing fetus from radiation exposure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Total Thyroidectomy</strong>: This option involves the complete removal of the thyroid gland and is a standard treatment for papillary thyroid carcinoma. However, the timing of the surgery during pregnancy should be carefully considered in consultation with an experienced healthcare team.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>B. Total Thyroidectomy plus Lymph Node Dissection</strong>: In cases where there is evidence of lymph node involvement or a high risk of lymph node metastasis, total thyroidectomy with lymph node dissection may be recommended to remove affected lymph nodes in the neck. Again, the timing and extent of surgery should be carefully evaluated during pregnancy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>D. Right Hemithyroidectomy</strong>: Right hemithyroidectomy involves the removal of one lobe (half) of the thyroid gland. This procedure is considered when there is a single, localized thyroid nodule or cancer confined to one side of the thyroid gland. However, for papillary carcinoma thyroid, total thyroidectomy is often preferred to ensure complete removal of the cancer.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Radioiodine ablation of thyroid is contraindicated in pregnant women due to risk of radiation exposure to the fetus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Therapeutic uses for Radioactive lodine</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">In primary thyrotoxicosis after the age of 45 years.</span></li><li><span style=\"font-size:12.0pt;\">In autonomous toxic nodule after 45 years, it is useful as remaining gland will still function adequately after radiotherapy.</span></li><li><span style=\"font-size:12.0pt;\">In papillary/follicular carcinoma of thyroid, after total thyroidectomy, if there are secondaries elsewhere in the body, as in bones or lungs, then I 131 is given.</span></li></ol>",
      "correct_choice_id": 56147,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13037,
      "choices": [
        {
          "id": 52110,
          "text": "<p><span style=\"font-size:12.0pt;\">Bansdola</span></p>"
        },
        {
          "id": 52111,
          "text": "<p><span style=\"font-size:12.0pt;\">Garroting</span></p>"
        },
        {
          "id": 52112,
          "text": "<p><span style=\"font-size:12.0pt;\">Mugging</span></p>"
        },
        {
          "id": 52113,
          "text": "<p><span style=\"font-size:12.0pt;\">Throttling</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The image below shows strangulation by Spanish windlass method. What type of strangulation method does it belong to? (INICET NOV 2022)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/image-37.jpg\" alt=\"\" width=\"300\" height=\"300\"></span></p>",
      "unique_key": "Q3573172",
      "question_audio": null,
      "question_video": null,
      "map_id": 12000007,
      "difficulty_level": "beginner",
      "subjects_id": [
        10
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Garroting</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Spanish windlass</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Method:</strong> It involves tightening an iron collar (Spanish windlass) around the neck and forcing a spike against the neck into the spinal cord.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Garroting</strong>- It involves attacking the victim by throwing the ligature from behind over the victim's neck and then tightened by twisting with a lever.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Bansdola: </strong>A method of strangulation where a ligature is applied in a different manner, often using a stick or rod to twist and tighten the ligature.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Mugging: </strong>Refers to a method where the assailant uses their limbs, such as the crook of their elbow, to compress the neck.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Throttling: </strong>Throttling involves using hands to manually compress the neck, leading to asphyxia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The Spanish windlass method of strangulation, shown in the image, belongs to the category of garroting, which involves the use of a ligature tightened by a lever or similar mechanism.</span></p>",
      "correct_choice_id": 52111,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 56081,
      "choices": [
        {
          "id": 223749,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Rifampin</span></span></span></p>"
        },
        {
          "id": 223750,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ofloxacin</span></span></span></p>"
        },
        {
          "id": 223751,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Minocycline</span></span></span></p>"
        },
        {
          "id": 223752,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Clarithromycin</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 42-year-old man presents to the clinic with a year-long history of worsening numbness in his extremities and progressive skin lesions. He has also noted muscle weakness, particularly in his hands, which has been affecting his daily activities. Physical examination reveals multiple hypopigmented and erythematous patches on his arms and legs with notable loss of sensation. There is thickening of the ulnar and posterior tibial nerves bilaterally. A skin biopsy confirms the diagnosis of leprosy. The physician plans to start multidrug therapy to manage the infection effectively. Which drug is considered the most bactericidal against Mycobacterium leprae?</span></span></span></p>",
      "unique_key": "Q4660599",
      "question_audio": null,
      "question_video": null,
      "map_id": 12000008,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<h3><span style=\"font-size:14pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"color:#434343\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ans. </span></span></span></strong><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A. Rifampin</span></span></strong></span></span></span></h3>\r\n\r\n<h3>&nbsp;</h3>\r\n\r\n<h3><span style=\"font-size:14pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"color:#434343\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Explanation:</span></span></span></strong></span></span></span></h3>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Rifampin is the most bactericidal drug against Mycobacterium leprae because it inhibits bacterial RNA polymerase, effectively blocking bacterial replication. This rapid bactericidal action is crucial in leprosy treatment, as it significantly reduces the bacterial load, thereby improving clinical outcomes and minimizing the risk of resistance. Rifampin&rsquo;s potency makes it an essential component of multidrug therapy, playing a central role in managing and controlling leprosy infections.</span></span></span></p>\r\n\r\n<h3>&nbsp;</h3>\r\n\r\n<h3><span style=\"font-size:14pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"color:#434343\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Other Options:</span></span></span></strong></span></span></span></h3>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option </span></strong><strong><span style=\"font-size:12.0pt\">B. Ofloxacin:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Ofloxacin, a fluoroquinolone, is used in the management of leprosy, particularly in cases involving drug resistance or intolerance to first-line medications. While it has bactericidal activity, it is considered secondary to rifampin&rsquo;s potency and is not the first-line choice for reducing bacterial load.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option </span></strong><strong><span style=\"font-size:12.0pt\">C. Minocycline:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Minocycline has anti-inflammatory and antibacterial properties and is used as an adjunct therapy in leprosy. However, its bactericidal effect is not as strong as rifampin, limiting its role to supportive treatment rather than primary bacterial eradication.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option </span></strong><strong><span style=\"font-size:12.0pt\">D. Clarithromycin:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Clarithromycin is a macrolide antibiotic that can be used in combination regimens for leprosy. However, its bactericidal action against Mycobacterium leprae is weaker compared to rifampin, making it an alternative rather than a primary bactericidal agent.</span></span></span></p>\r\n\r\n<h3>&nbsp;</h3>\r\n\r\n<h3><span style=\"font-size:14pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"color:#434343\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Educational Objective:</span></span></span></strong></span></span></span></h3>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Rifampin is the most potent bactericidal drug against Mycobacterium leprae and is a critical component of multidrug therapy for leprosy. Its ability to rapidly reduce the bacterial load is essential in preventing disease progression and minimizing resistance, ensuring effective management of the infection.</span></span></span></p>",
      "correct_choice_id": 223749,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9770,
      "choices": [
        {
          "id": 39047,
          "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Philadelphia chromosome</span></span></span></p>"
        },
        {
          "id": 39048,
          "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">JAK mutation</span></span></span></p>"
        },
        {
          "id": 39049,
          "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Erythropoietin levels</span></span></span></p>"
        },
        {
          "id": 39050,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Bone Marrow biopsy with reticulin stain</span></span></span></p>"
        }
      ],
      "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A young boy from high altitude came with fever and weakness and had the following reports Hemoglobin 17 gm%, TLC is 21,000 with neutrophils 25, lymphocytes 30, eosinophils 5, myelocytes and metamyelocytes 40 in peripheral smear. Next step in the investigation should be:&nbsp;</span></span></span>(AIIMS MAY 2019)</p>",
      "unique_key": "Q3753095",
      "question_audio": null,
      "question_video": null,
      "map_id": 12000009,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Erythropoietin levels</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The given clinical scenario is suggestive of polycythemia (Hb&gt;16 g/dL). Erythropoietin levels should be determined to differentiate primary from secondary forms.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Polycythemia vera (PCV) is characterized by increased marrow production of red cells, granulocytes, and platelets (panmyelosis), but it is the increase in red cells (polycythemia), that is responsible for most of the clinical symptoms. PCV must be differentiated from relative polycythemia resulting from hemoconcentration and other causes of absolute polycythemia. PCV is strongly associated with activating point mutations in the tyrosine kinase JAK2.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In PCV the progenitor cells have markedly decreased requirements for erythropoietin and other hematopoietic growth factors due to constitutive JAK2 signaling. Accordingly, serum erythropoietin levels in PCV are very low, whereas secondary forms of absolute polycythemia have high erythropoietin levels.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/02/screenshot-2024-09-02-113555.png\" style=\"height:613px; width:1000px\" /></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Philadelphia chromosome</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This test is relevant in diagnosing chronic myeloid leukemia (CML), not polycythemia. While the presence of immature myeloid cells (myelocytes and metamyelocytes) could suggest a myeloproliferative disorder, the patient&#39;s clinical presentation and high hemoglobin level are more consistent with polycythemia, making erythropoietin testing a more appropriate next step.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. JAK mutation</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Testing for the JAK2 mutation is crucial in confirming a diagnosis of PCV. However, before proceeding to this test, it is important to measure erythropoietin levels to differentiate between primary and secondary polycythemia. If erythropoietin levels are low, JAK2 mutation analysis would then be the next step.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Bone Marrow biopsy with reticulin stain</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This investigation is used to evaluate bone marrow fibrosis, which can occur in myeloproliferative disorders like PCV. However, it is not the first-line investigation in this scenario. The erythropoietin level is a less invasive test that provides critical information to guide further diagnostic steps.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Erythropoietin levels should be measured to differentiate between primary and secondary polycythemia. In cases of polycythemia vera, erythropoietin levels are typically low due to constitutive JAK2 signaling, while secondary polycythemia is associated with high erythropoietin levels.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ref: Robbins and Cortans pathologic basis of disease, Pg 1161, 1242</span></strong></span></span></p>",
      "correct_choice_id": 39049,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5921,
      "choices": [
        {
          "id": 23654,
          "text": "<p><span style=\"font-size:12.0pt;\">Metronidazole</span></p>"
        },
        {
          "id": 23655,
          "text": "<p><span style=\"font-size:12.0pt;\">Fluconazole</span></p>"
        },
        {
          "id": 23656,
          "text": "<p><span style=\"font-size:12.0pt;\">Tetracycline</span></p>"
        },
        {
          "id": 23657,
          "text": "<p><span style=\"font-size:12.0pt;\">Cefixime</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A female patient having frothy vaginal discharge was found to have a strawberry cervix. Which of the following is the drug of choice?&nbsp;</span>(INICET MAY 2021)</p>",
      "unique_key": "Q5912024",
      "question_audio": null,
      "question_video": null,
      "map_id": 12000010,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Metronidazole</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">The description of a frothy vaginal discharge and a \"strawberry cervix\" is characteristic of <strong>trichomoniasis vaginalis</strong>, a common sexually transmitted infection caused by the protozoan Trichomonas vaginalis. The drug of choice for treating trichomoniasis is <strong>Metronidazole</strong>. This medication can be administered as a single high dose (2g) or in a lower dose (200mg three times daily for 7 days).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Fluconazole</strong>: This drug is used for treating candidiasis (yeast infections), not trichomoniasis. Candidiasis typically presents with a curdy white discharge rather than frothy discharge and is not associated with a strawberry cervix.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Tetracycline</strong>: Tetracycline is an antibiotic used for various bacterial infections but is not effective against trichomoniasis. It is not the drug of choice for treating this parasitic infection.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Cefixime</strong>: Cefixime is a cephalosporin antibiotic used to treat bacterial infections like gonorrhea. It is not effective against trichomoniasis and thus is not appropriate for this condition.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/05/screenshot-2024-08-05-164120.png\" alt=\"\" width=\"1000\" height=\"434\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">The drug of choice for treating trichomoniasis vaginalis, which presents with frothy vaginal discharge and strawberry cervix, is Metronidazole.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Page no 554, DC Dutta’s Textbook of gynecology 6<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 23654,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14595,
      "choices": [
        {
          "id": 58341,
          "text": "<p><span style=\"font-size:12.0pt;\">Pelviureteric junction obstruction</span></p>"
        },
        {
          "id": 58342,
          "text": "<p><span style=\"font-size:12.0pt;\">Putty kidney</span></p>"
        },
        {
          "id": 58343,
          "text": "<p><span style=\"font-size:12.0pt;\">Staghorn calculus</span></p>"
        },
        {
          "id": 58344,
          "text": "<p><span style=\"font-size:12.0pt;\">Cystic kidney</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 28-year-old female presented to the urologist with complaints of abdominal pain and recurrent urinary tract infections. Upon examination, the physician noted tenderness in the lower abdomen and a palpable mass in the right flank area. Further evaluation revealed the following. What is the likely diagnosis?&nbsp; (NEET PG 2022)</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:11pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/07/ns21.jpg\" alt=\"\" width=\"258\" height=\"194\"></span></p>",
      "unique_key": "Q9456246",
      "question_audio": null,
      "question_video": null,
      "map_id": 12000011,
      "difficulty_level": "beginner",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Pelviureteric junction obstruction</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The clinical scenario and the imaging indicate a likely diagnosis of pelviureteric junction (PUJ) obstruction.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Pelviureteric junction obstruction is a condition where there is a blockage at the point where the renal pelvis meets the ureter.</span></li><li><span style=\"font-size:12pt;\">This blockage can lead to hydronephrosis, which is the swelling of a kidney due to a buildup of urine.</span></li><li><span style=\"font-size:12pt;\">PUJ obstruction can be congenital (present at birth) or acquired. Symptoms can include flank pain, recurrent UTIs, and a palpable mass in severe cases.</span></li><li><span style=\"font-size:12pt;\">The findings from imaging studies, showing hydronephrosis (dilated pelvicalyceal system), would support this diagnosis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Putty kidney:</strong> A putty kidney refers to a kidney that has been extensively damaged by tuberculosis. The kidney appears pale, and is often shrunk, firm, and non-functional. It would not typically cause a palpable mass and recurrent UTIs in the described manner of the patient in the question.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Staghorn calculus:</strong> Staghorn calculi are large kidney stones that occupy a large portion of the renal pelvis and its calyces, often having a shape resembling a stag's horn. They can lead to recurrent UTIs and can sometimes be palpable, especially if the kidney is also enlarged due to obstruction. However, the description in the question and the image seems more indicative of an obstruction at the PUJ rather than a staghorn calculus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Cystic kidney:</strong> A cystic kidney, as the name suggests, is characterized by multiple cysts in the kidney. There are several diseases, like polycystic kidney disease, that can lead to cyst formation in kidneys. These cysts can sometimes cause pain, enlarged kidneys, and in some cases, recurrent UTIs. However, the specific findings from the imaging study mentioned in the question don't necessarily align with a simple cystic kidney diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Given the findings mentioned in the question, a palpable mass in the right flank area, tenderness in the lower abdomen, and imaging results, Pelviureteric junction obstruction (Option A) is the most consistent and likely diagnosis for the patient.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Pelviureteric junction obstruction is a condition causing blockage where the renal pelvis meets the ureter, leading to hydronephrosis and symptoms like flank pain and recurrent UTIs.</span></li><li><span style=\"font-size:12pt;\">Imaging typically shows a dilated pelvicalyceal system.</span></li></ul>",
      "correct_choice_id": 58341,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 31805,
      "choices": [
        {
          "id": 127090,
          "text": "<p><span style=\"font-size:12pt;\">Tacrolimus</span></p>"
        },
        {
          "id": 127091,
          "text": "<p><span style=\"font-size:12pt;\">Nifedipine</span></p>"
        },
        {
          "id": 127092,
          "text": "<p><span style=\"font-size:12pt;\">Diltiazem</span></p>"
        },
        {
          "id": 127093,
          "text": "<p><span style=\"font-size:12pt;\">Verapamil</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which of the following drugs is an inhibitor of ATP binding cassette efflux pumps? (INICET NOV 2023)</span></p>",
      "unique_key": "Q6250504",
      "question_audio": null,
      "question_video": null,
      "map_id": 12000012,
      "difficulty_level": "difficult",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) Verapamil</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Verapamil is known to inhibit the activity of ATP-binding cassette (ABC) transporters, such as P-glycoprotein, which is one of the most well-studied drug efflux transporters. By inhibiting P-glycoprotein, verapamil can increase the intracellular concentration of various drugs, which is why it is sometimes used as a pharmacokinetic enhancer to improve drug absorption and decrease drug clearance.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Tacrolimus:</strong> Tacrolimus is an immunosuppressant drug used mainly after allogeneic organ transplant to reduce the activity of the patient's immune system and lower the risk of organ rejection. It is not an inhibitor of the ATP-binding cassette efflux transporters.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Nifedipine:</strong> Nifedipine is a calcium channel blocker used primarily to treat hypertension and angina pectoris. It is not known to inhibit ABC efflux transporters.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Diltiazem:</strong> Diltiazem, like verapamil, is a calcium channel blocker, but it is not as potent as verapamil in inhibiting P-glycoprotein. However, it does have some effect on drug efflux transporters, but to a lesser extent compared to verapamil.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Verapamil is a known inhibitor of ATP-binding cassette transporters, particularly P-glycoprotein, and can be used to enhance the pharmacokinetics of various drugs by increasing their intracellular concentrations.</span></p>",
      "correct_choice_id": 127093,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13945,
      "choices": [
        {
          "id": 55741,
          "text": "<p><span style=\"font-size:12.0pt;\">Strap his thorax, abdomen and lower limbs on a stretcher</span></p>"
        },
        {
          "id": 55742,
          "text": "<p><span style=\"font-size:12.0pt;\">Apply a cervical collar</span></p>"
        },
        {
          "id": 55743,
          "text": "<p><span style=\"font-size:12.0pt;\">Put patient on lateral position and shift him immediately</span></p>"
        },
        {
          "id": 55744,
          "text": "<p><span style=\"font-size:12.0pt;\">Roll the patient and put on a hard board</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All of the following are done to transport a polytrauma patient who is conscious except? (AIIMS MAY 2017)</span></p>",
      "unique_key": "Q9309920",
      "question_audio": null,
      "question_video": null,
      "map_id": 12000013,
      "difficulty_level": "intermediate",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Put patient on lateral position and shift him immediately</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This option is not a standard practice when transporting conscious polytrauma patients. Shifting a conscious patient to a lateral position and immediately moving them can risk further injury and discomfort.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Strap his thorax, abdomen, and lower limbs on a stretcher:&nbsp;</strong>This is a common and necessary practice when transporting a conscious polytrauma patient. It helps secure the patient to the stretcher to prevent movement and further injury during transport.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Apply a cervical collar:&nbsp;</strong>This is done to immobilize the cervical spine, till a cervical injury is ruled out.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Roll the patient and put on a hardboard:&nbsp;</strong>Rolling a conscious polytrauma patient and placing them on a hardboard (spinal board) can be a part of the standard protocol for immobilizing the spine and minimizing movement during transport. This is done to prevent potential spinal cord injuries.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Patients with polytrauma are shifted in supine or prone position (not in lateral position) by laying them over a firm surface, in order to restrict the spinal movement.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">As per ATLS guidelines, in patients with trauma, airway management is first done along with cervical spine stabilization. All trauma patients unless proven otherwise are considered to have an injured vertebral column.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient is placed supine on a firm surface without rotating or bending the spinal column and a rigid cervical collar (Philadelphia collar) is applied.</span></p>",
      "correct_choice_id": 55743,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14133,
      "choices": [
        {
          "id": 56493,
          "text": "<p><span style=\"font-size:12.0pt;\">Posterior urethral valve</span></p>"
        },
        {
          "id": 56494,
          "text": "<p><span style=\"font-size:12.0pt;\">Urethral atresia</span></p>"
        },
        {
          "id": 56495,
          "text": "<p><span style=\"font-size:12.0pt;\">Anterior urethral valve</span></p>"
        },
        {
          "id": 56496,
          "text": "<p><span style=\"font-size:12.0pt;\">Ureterocele</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The leading cause of bladder outlet obstruction in male children is: (INICET NOV 2021)</span></p>",
      "unique_key": "Q9201817",
      "question_audio": null,
      "question_video": null,
      "map_id": 12000014,
      "difficulty_level": "beginner",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Posterior urethral valve</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This is the most common cause of lower urinary tract obstruction in male infants. PUV is a congenital malformation found only in boys where there is an abnormal fold of tissue in the posterior urethra, preventing normal urine outflow and leading to bladder outlet obstruction. The condition can lead to hydronephrosis if not treated promptly.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Urethral atresia</strong>: This is a rare congenital anomaly where a segment of the urethra fails to canalize or develop. It leads to complete obstruction of the urethra, and while it does cause bladder outlet obstruction, it is less common than PUV in male children.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Anterior urethral valve</strong>: This is a rare congenital anomaly and is much less common than the posterior urethral valve. While it can cause obstruction, its prevalence and significance in causing bladder outlet obstruction in male children are far less than that of PUV.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Ureterocele</strong>: A ureterocele is a cystic dilation of the terminal ureter within the bladder. It can cause obstruction of the ureter itself. They are not the leading cause in male children when compared to PUV.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The most frequent cause of bladder outflow obstruction in male children is the posterior urethral valve (PUV).</span></li><li><span style=\"font-size:12.0pt;\">PUV is a membranous fold located in the posterior urethra, typically found just distal to the verumontanum. It is thought to occur due to the persistence of the urogenital membrane.</span></li><li><span style=\"font-size:12.0pt;\">Urethral obstruction can cause dilation of the posterior urethral valve, bladder, and bilateral hydronephrosis, leading to a keyhole sign on prenatal ultrasound and potentially oligohydramnios.</span></li><li><span style=\"font-size:12.0pt;\">If not detected prenatally, PUV may present postnatally as a newborn or young infant with urinary tract symptoms, abdominal distension or and recurrent UTIs.</span></li><li><span style=\"font-size:12.0pt;\">Left untreated, PUV may result in chronic kidney disease, bladder dysfunction, and vesicoureteral reflux.</span></li><li><span style=\"font-size:12.0pt;\">Diagnosis of PUV is typically based on the presence of an elongated posterior valve during the voiding phase of the voiding cystourethrogram (VCUG).</span></li></ul>",
      "correct_choice_id": 56493,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 56082,
      "choices": [
        {
          "id": 223753,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Coronary vasoconstriction</span></span></span></p>"
        },
        {
          "id": 223754,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Decreased platelet aggregation</span></span></span></p>"
        },
        {
          "id": 223755,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Peripheral vasodilation</span></span></span></p>"
        },
        {
          "id": 223756,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Beta-adrenergic blockade</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 68-year-old woman with a history of ischemic heart disease presents to the emergency department with acute onset of chest pain that started an hour ago. She describes the pain as squeezing and located in the center of her chest. Her medical history is significant for long-standing migraines, for which she recently started a new medication. Physical examination shows an anxious but stable patient with a blood pressure of 140/90 mmHg and a heart rate of 85 beats per minute. An ECG reveals ST-segment depression in the lateral leads. The physician suspects that her chest pain may be related to her migraine treatment. Which mechanism of her migraine medication could have contributed to her chest pain?</span></span></span></p>",
      "unique_key": "Q4362649",
      "question_audio": null,
      "question_video": null,
      "map_id": 12000075,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<h3><span style=\"font-size:14pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"color:#434343\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ans. </span></span></span></strong><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A. Coronary vasoconstriction</span></span></strong></span></span></span></h3>\r\n\r\n<h3>&nbsp;</h3>\r\n\r\n<h3><span style=\"font-size:14pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"color:#434343\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Explanation:</span></span></span></strong></span></span></span></h3>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient&rsquo;s chest pain is likely due to coronary vasoconstriction caused by her migraine medication. Many migraine medications, particularly triptans (such as sumatriptan), work by activating serotonin (5-HT1) receptors, which not only relieve migraine symptoms but also cause vasoconstriction of blood vessels, including coronary arteries. This vasoconstriction can exacerbate ischemic heart disease and lead to angina or other ischemic symptoms, especially in patients with a known history of coronary artery disease.</span></span></span></p>\r\n\r\n<h3>&nbsp;</h3>\r\n\r\n<h3><span style=\"font-size:14pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"color:#434343\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Other Options:</span></span></span></strong></span></span></span></h3>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option </span></strong><strong><span style=\"font-size:12.0pt\">B. Decreased platelet aggregation:&nbsp;</span></strong><span style=\"font-size:12.0pt\">This is incorrect because decreased platelet aggregation would theoretically reduce the risk of ischemic events rather than provoke chest pain. Medications like aspirin work through this mechanism but are not associated with triggering ischemic symptoms.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option </span></strong><strong><span style=\"font-size:12.0pt\">C. Peripheral vasodilation:&nbsp;</span></strong><span style=\"font-size:12.0pt\">This is incorrect because peripheral vasodilation would decrease afterload and improve blood flow, which typically helps alleviate chest pain rather than cause it. Medications such as nitrates use this mechanism to relieve angina.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option </span></strong><strong><span style=\"font-size:12.0pt\">D. Beta-adrenergic blockade:&nbsp;</span></strong><span style=\"font-size:12.0pt\">This is incorrect because beta-blockers reduce myocardial oxygen demand by slowing the heart rate and decreasing contractility, which usually helps manage ischemic heart disease and prevent chest pain, not exacerbate it.</span></span></span></p>\r\n\r\n<h3>&nbsp;</h3>\r\n\r\n<h3><span style=\"font-size:14pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"color:#434343\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Educational Objective:</span></span></span></strong></span></span></span></h3>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Migraine medications, particularly triptans, can induce coronary vasoconstriction due to their serotonin receptor agonist activity. In patients with a history of ischemic heart disease, these medications can precipitate or worsen chest pain, highlighting the need for careful selection of migraine therapies in this population.</span></span></span></p>",
      "correct_choice_id": 223753,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2543,
      "choices": [
        {
          "id": 10157,
          "text": "<p><span style=\"font-size:12.0pt;\">Has reverse transcriptase activity</span></p>"
        },
        {
          "id": 10158,
          "text": "<p><span style=\"font-size:12.0pt;\">Present only in Eukaryotes</span></p>"
        },
        {
          "id": 10159,
          "text": "<p><span style=\"font-size:12.0pt;\">Maintain the chromosome length</span></p>"
        },
        {
          "id": 10160,
          "text": "<p><span style=\"font-size:12.0pt;\">Involved in DNA Repair</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not a true statement regarding telomerase? (INICET NOV 2020)</span></p>",
      "unique_key": "Q1503429",
      "question_audio": null,
      "question_video": null,
      "map_id": 12000096,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Involved in DNA repair</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Telomerase is not primarily involved in DNA repair. While telomere maintenance can influence genome stability and prevent end-to-end chromosome fusions, telomerase itself does not play a direct role in the classical DNA repair pathways such as base excision repair, nucleotide excision repair, mismatch repair, or double-strand break repair.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Telomerase is a specialized enzyme that adds repetitive nucleotide sequences to the ends of chromosomes (telomeres) in eukaryotic cells. Its primary function is to maintain the length and stability of chromosomes by compensating for the loss of DNA that occurs during cell division.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Additional Information:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Telomeres are repetitive non-coding DNA sequences at the ends of chromosomes that protect them from degradation and prevent chromosomal fusion.</span></li><li><span style=\"font-size:12.0pt;\">Telomerase activity declines with age, leading to the progressive shortening of telomeres and eventual cell senescence or apoptosis.</span></li><li><span style=\"font-size:12.0pt;\">In many cancer cells, telomerase activity is upregulated, allowing these cells to bypass senescence and continue dividing indefinitely.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Has reverse transcriptase activity:</strong> Telomerase contains an RNA component that serves as a template for adding telomeric repeats to the chromosome ends. The enzyme uses this RNA template to synthesize DNA, acting as a reverse transcriptase.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Present only in Eukaryotes:</strong> Telomerase is found only in eukaryotic cells because prokaryotic chromosomes are typically circular and do not have telomeres that require maintenance.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Maintains the chromosome length:</strong> Telomerase extends the telomeres, preventing their shortening during DNA replication and thus maintaining chromosome length and stability.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><span style=\"font-size:10.5pt;\"><strong>&nbsp;</strong></span></p><p><span style=\"font-size:12.0pt;\">Telomerase is an enzyme with reverse transcriptase activity, present only in eukaryotes, and is crucial for maintaining chromosome length by adding telomeric repeats. It is not directly involved in DNA repair.</span></p>",
      "correct_choice_id": 10160,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16129,
      "choices": [
        {
          "id": 64476,
          "text": "<p><span style=\"font-size:12pt;\">Stage 1</span></p>"
        },
        {
          "id": 64477,
          "text": "<p><span style=\"font-size:12pt;\">Stage 2</span></p>"
        },
        {
          "id": 64478,
          "text": "<p><span style=\"font-size:12pt;\">Stage 3</span></p>"
        },
        {
          "id": 64479,
          "text": "<p><span style=\"font-size:12pt;\">Stage 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">During a surgical procedure on a patient exhibiting symptoms indicative of peritonitis, a diverticular rupture is observed, accompanied by fecal peritonitis. What would be the corresponding stage according to the Hinchey's classification?&nbsp;(NEET PG 2020)</span></p>",
      "unique_key": "Q5920310",
      "question_audio": null,
      "question_video": null,
      "map_id": 12000097,
      "difficulty_level": "beginner",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) Stage 4</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Hinchey's Classification is used to describe the severity of perforated diverticular disease. It helps guide the management of diverticulitis by categorizing the condition into different stages based on the clinical presentation and severity of the disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Hinchey's Classification Stages:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Stage 0</strong>: Mild clinical diverticulitis with symptoms such as left lower quadrant abdominal pain, low-grade fever, and leukocytosis. Management typically includes oral antibiotics.</span></li><li><span style=\"font-size:12pt;\"><strong>Stage Ia</strong>: Confined pericolic inflammation or phlegmon. This stage can be managed with antibiotics, with or without CT-guided drainage.</span></li><li><span style=\"font-size:12pt;\"><strong>Stage Ib</strong>: Confined pericolic abscess. Similar to Stage Ia, management includes antibiotics, with or without CT-guided drainage.</span></li><li><span style=\"font-size:12pt;\"><strong>Stage II</strong>: Distant abscess. This requires abscess drainage, often through percutaneous methods.</span></li><li><span style=\"font-size:12pt;\"><strong>Stage III</strong>: Purulent peritonitis. This stage involves the presence of pus in the peritoneal cavity, usually managed with Hartmann's surgery.</span></li><li><span style=\"font-size:12pt;\"><strong>Stage IV</strong>: Fecal peritonitis. This stage indicates the presence of fecal matter in the peritoneal cavity due to a perforated diverticulum, and it is managed with Hartmann's surgery.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In the given scenario, the patient has a diverticular rupture with fecal peritonitis, which corresponds to <strong>Stage IV</strong> in Hinchey's classification.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Stage 1: </strong>Stage 1 is divided into Stage Ia and Stage Ib. Stage Ia involves confined pericolic inflammation or phlegmon, while Stage Ib involves a confined pericolic abscess. Neither of these stages includes peritonitis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Stage 2: </strong>Stage 2 involves the presence of a distant abscess. This stage does not include peritonitis and is managed with abscess drainage.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Stage 3:</strong> Stage 3 involves purulent peritonitis, which includes the presence of pus in the peritoneal cavity. However, it does not involve fecal contamination.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Hinchey's Classification of diverticulitis is essential for determining the appropriate management strategy. Stage IV in Hinchey's classification corresponds to fecal peritonitis, which requires immediate surgical intervention, typically Hartmann's surgery.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/09/screenshot-2024-07-09-161905.jpg\" alt=\"\" width=\"1000\" height=\"748\"></p>",
      "correct_choice_id": 64479,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "CriteriaBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 56083,
      "choices": [
        {
          "id": 223757,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Both A and B are full agonists</span></span></span></p>"
        },
        {
          "id": 223758,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">B is more potent than A</span></span></span></p>"
        },
        {
          "id": 223759,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">C is a noncompetitive antagonist</span></span></span></p>"
        },
        {
          "id": 223760,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A is more efficacious than B, but potency is the same</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Referencing the provided dose-response curves for three drugs (A, B, C), which of the following statements is true? (AIIMS NOV 2016)</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/06/untitled-3666.jpg\" style=\"height:289px; width:400px\" /></p>",
      "unique_key": "Q5052838",
      "question_audio": null,
      "question_video": null,
      "map_id": 12000098,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. &nbsp;A. Both A and B are full agonists</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The dose-response curves for drugs A and B reach the same maximum effect, indicative of full agonists, as they are capable of eliciting the maximum possible response. Both curves ascend to a similar plateau, demonstrating that both drugs achieve full receptor activation with maximal efficacy. In pharmacology, full agonists have the ability to fully activate the receptor they bind to, producing a maximum biological response that mimics the action of the body&#39;s own regulating molecules<strong>.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other options:</span></strong></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">B. B is more potent than A:</span></strong><span style=\"font-size:12.0pt\"> Potency is determined by the concentration of the drug needed to produce a given effect. Without numerical values or clearer graphical differentiation on potency from the graph, this statement cannot be confirmed as correct solely based on the visual representation provided.</span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">C. C is a noncompetitive antagonist:</span></strong><span style=\"font-size:12.0pt\"> The curve for C does not show a flat line or suppression of the maximal response, which would indicate a noncompetitive antagonist. Instead, it appears to reach a lesser maximum than A and B, suggesting it is possibly a partial agonist.</span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">D. A is more efficacious than B, but potency is the same:</span></strong><span style=\"font-size:12.0pt\"> As both A and B reach the same maximal effect, their efficacy is the same. There is no evidence from the curve that they differ in potency based solely on the provided information.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Both A and B are full agonists because they achieve the same maximum pharmacological effect, indicating full activation of the receptors they bind .</span></span></span></p>",
      "correct_choice_id": 223757,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 44819,
      "choices": [
        {
          "id": 178923,
          "text": "<p><span style=\"font-size:12pt;\">Conjugated estrogen</span></p>"
        },
        {
          "id": 178924,
          "text": "<p><span style=\"font-size:12pt;\">Estrone</span></p>"
        },
        {
          "id": 178925,
          "text": "<p><span style=\"font-size:12pt;\">Estradiol</span></p>"
        },
        {
          "id": 178926,
          "text": "<p><span style=\"font-size:12pt;\">Estriol</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Most potent natural estrogen is (INICET MAY 2024)</span></p>",
      "unique_key": "Q6840690",
      "question_audio": null,
      "question_video": null,
      "map_id": 12000149,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) Estradiol</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Estradiol (E2) is the most potent natural estrogen. It is the primary estrogen produced by the ovaries during the reproductive years and plays a crucial role in regulating the menstrual cycle and reproductive system.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option&nbsp;A.</strong>&nbsp;<strong>Conjugated estrogen</strong>: Conjugated estrogen like Ethinyl estradiol is a synthetic estrogen commonly used in oral contraceptives. It is not a natural estrogen.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option&nbsp;B.</strong>&nbsp;<strong>Estrone</strong>: Estrone (E1) is one of the three naturally occurring estrogens. It is less potent than estradiol. Estrone is primarily produced in adipose tissue and is the predominant estrogen after menopause.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option&nbsp;D.</strong>&nbsp;<strong>Estriol</strong>: Estriol (E3) is the weakest of the three natural estrogens. It is primarily produced during pregnancy by the placenta. Estriol has much lower estrogenic activity compared to estradiol and estrone.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In summary, estradiol is the most potent natural estrogen and plays a significant role in the female reproductive system during the reproductive years.</span></p>",
      "correct_choice_id": 178925,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5891,
      "choices": [
        {
          "id": 23534,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">First trimester</span></span></span></p>"
        },
        {
          "id": 23535,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Second trimester</span></span></span></p>"
        },
        {
          "id": 23536,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Third trimester</span></span></span></p>"
        },
        {
          "id": 23537,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Both (a) and (b)</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In which trimester does acute fatty liver manifest most commonly during pregnancy?</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> (NEET PG 2019)</span></span></p>",
      "unique_key": "Q7134299",
      "question_audio": null,
      "question_video": null,
      "map_id": 12000150,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Third trimester </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acute fatty liver of pregnancy (AFLP) is a life-threatening medical disorder that primarily affects the liver during pregnancy. It most commonly manifests in the late second and third trimesters. AFLP is characterized by the accumulation of microvesicular fat within hepatocytes, leading to liver dysfunction. The diagnosis of AFLP is made using the Swansea criteria, which require six or more of the following clinical features for diagnosis:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vomiting</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Abdominal pain</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Polydipsia, polyuria</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Encephalopathy</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Coagulopathy (raised PT, aPTT)</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased bilirubin</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased uric acid levels</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased creatinine</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Leukocytosis</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypoglycemia</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Raised liver enzymes</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Raised serum ammonia levels</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ascites or bright liver on ultrasound</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Microvascular steatosis on liver biopsy</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Risk Factors:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Maternal obesity</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Male fetus</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Primigravida</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Multiple pregnancy</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. First trimester</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: AFLP is very rare in the first trimester, as it typically manifests later in pregnancy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Second trimester</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: While AFLP can begin in the late second trimester, it is more commonly seen in the third trimester.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Both (a) and (b)</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: AFLP does not commonly manifest in the first trimester and is primarily a condition of the late second and third trimesters.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acute fatty liver of pregnancy most commonly manifests in the third trimester and is diagnosed using the Swansea criteria, requiring six or more specific clinical features.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page no 2684, Williams Obstetrics 26<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 23536,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 30722,
      "choices": [
        {
          "id": 122766,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Paracetamol</span></span></span></span></p>"
        },
        {
          "id": 122767,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Valproate</span></span></span></span></p>"
        },
        {
          "id": 122768,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Warfarin</span></span></span></span></p>"
        },
        {
          "id": 122769,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Tetracycline</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Most&nbsp;</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">commonly implicated drug for causation of acute liver failure is? (AIIMS MAY 2020</span></span></span></span><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">)</span></span></span></span></p>",
      "unique_key": "Q3772003",
      "question_audio": null,
      "question_video": null,
      "map_id": 12000151,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Ans.&nbsp;</span></span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">A. Paracetamol</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">All the four drugs given Paracetamol, Valproate, Warfarin and Tetracyclines can cause hepatotoxicity. Paracetamol among these is the most common cause particularly in patients with liver disease and in alcoholics.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Paracetamol is the most common cause of acute liver failure in many countries, particularly in the context of overdose. It can cause severe hepatotoxicity, which can lead to acute liver failure, especially when taken in doses exceeding recommended levels or in individuals with certain risk factors (such as existing liver disease and chronic alcohol use etc.).</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Other Options: </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"color:#333333\"><strong>Option B.</strong>&nbsp;</span></span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\"><strong>Valproate</strong>: While valproate can cause hepatotoxicity, it is less commonly associated with acute liver failure compared to paracetamol. It is more frequently a concern in certain populations, such as young children and individuals on multiple anticonvulsants.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"color:#333333\"><strong>Option C.</strong>&nbsp;</span></span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\"><strong>Warfarin</strong>: Warfarin is an anticoagulant and is not commonly associated with acute liver failure. Its primary risk is bleeding due to its anticoagulant effects.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"color:#333333\"><strong>Option D.</strong>&nbsp;</span></span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\"><strong>Tetracycline</strong>: High doses of tetracycline, especially the older formulations, can cause liver toxicity, but it is not the most common drug causing acute liver failure. Tetracycline-induced liver injury is now relatively rare due to the decreased use of high-dose intravenous forms.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Paracetamol (acetaminophen) is the most common drug implicated in the causation of acute liver failure, especially in the context of overdose and in individuals with risk factors like existing liver disease and chronic alcohol use.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Reference: - KDT 8<sup>TH</sup>/223</span></span></strong></span></span></p>",
      "correct_choice_id": 122766,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24694,
      "choices": [
        {
          "id": 98737,
          "text": "<p><span style=\"font-size:12.0pt;\">Allen's test</span></p>"
        },
        {
          "id": 98738,
          "text": "<p><span style=\"font-size:12.0pt;\">Adson's test</span></p>"
        },
        {
          "id": 98739,
          "text": "<p><span style=\"font-size:12.0pt;\">Elevated arm stress test</span></p>"
        },
        {
          "id": 98740,
          "text": "<p><span style=\"font-size:12.0pt;\">Nicoladoni's test</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Before conducting an A-V fistula procedure, which of the following tests is typically conducted? The image of the test is given below: </span><span style=\"font-size:11.0pt;\">(</span><span style=\"font-size:12.0pt;\">INICET MAY 2023)</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/12/surgery-q-bank-1-min.jpg\" alt=\"\" width=\"300\" height=\"379\"></span></p>",
      "unique_key": "Q5643261",
      "question_audio": null,
      "question_video": null,
      "map_id": 12000152,
      "difficulty_level": "beginner",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Allen's test</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The given image represents Allen’s test, which indicates the patency of the radial and ulna artery in supplying the hand. Both arteries are compressed alternatively, to check if limb will survive in absence of radial artery (which will be now used in creation of AV fistula).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Adson's</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\"><strong>test</strong>: Adson's test is a provocative test for&nbsp;Thoracic Outlet Syndrome&nbsp;accompanied by compression of the subclavian artery by a cervical rib or tightened anterior and middle scalene muscles. Patient is asked to turn his head to affected side and take a deep breath. Ipsilateral radial pulse will become weak in thoracic outlet syndrome.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/12/3.jpg\" alt=\"\" width=\"300\" height=\"252\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Elevated arm</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\"><strong>stress</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\"><strong>test</strong>: Elevated arm stress test is a diagnostic tool used in the identification of Thoracic Outlet Syndrome. The patient is asked to abduct his shoulder and flex his forearm and open and close his fists. In presence of thoracic outlet syndrome, the affected limb will get cramps (ischemic) or paresthesia (neurogenic).</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/12/image-3-min.jpg\" alt=\"\" width=\"400\" height=\"265\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Nicoladoni's test</strong>: Nicoladoni's test is to be elicited in cases of AV fistula. There is slowing of heart rate in response to manual compression of fistula.</span></p>",
      "correct_choice_id": 98737,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6482,
      "choices": [
        {
          "id": 25897,
          "text": "<p><span style=\"font-size:12.0pt;\">6-Mercaptopurine</span></p>"
        },
        {
          "id": 25898,
          "text": "<p><span style=\"font-size:12.0pt;\">Mitomycin</span></p>"
        },
        {
          "id": 25899,
          "text": "<p><span style=\"font-size:12.0pt;\">Actinomycin</span></p>"
        },
        {
          "id": 25900,
          "text": "<p><span style=\"font-size:12.0pt;\">Asparaginase</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 55-year-old female patient with a history of advanced-stage colorectal cancer is being evaluated for a new chemotherapy regimen. The oncologist is considering drugs that would inhibit DNA synthesis as a part of her treatment. Which of the following drugs is a known inhibitor of DNA synthesis?</span><span style=\"font-size:10.5pt;\"> </span><span style=\"font-size:12.0pt;\">(NEET PG 2020)</span></p>",
      "unique_key": "Q8346258",
      "question_audio": null,
      "question_video": null,
      "map_id": 12000153,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) 6-Mercaptopurine</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">6-Mercaptopurine is a purine analog that acts by inhibiting the purine synthesis, required for the synthesis of DNA, in the S phase of the cell cycle.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Mitomycin</strong> acts as an alkylating agent which leads to DNA damage by creating cross links.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Actinomycin</strong> acts by creating single-strand breaks in DNA. It blocks RNA transcription as well.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D.</strong> <strong>L-Asparaginase </strong>causes the breakdown of asparagine and thus interferes with protein synthesis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">6-Mercaptopurine is a purine analog that inhibits DNA synthesis by interfering with purine synthesis, making it a critical component in chemotherapy regimens that aim to inhibit cell proliferation.</span></p>",
      "correct_choice_id": 25897,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7050,
      "choices": [
        {
          "id": 28168,
          "text": "<p><span style=\"font-size:12.0pt;\">Adequate safety profile needs to be established</span></p>"
        },
        {
          "id": 28169,
          "text": "<p><span style=\"font-size:12.0pt;\">Cost to benefit has to be considered</span></p>"
        },
        {
          "id": 28170,
          "text": "<p><span style=\"font-size:12.0pt;\">Fixed dose combination of drugs is preferred over single drugs</span></p>"
        },
        {
          "id": 28171,
          "text": "<p><span style=\"font-size:12.0pt;\">Disease prevalence is considered</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which of the following is false about the selection of essential drugs? (INICET MAY 2021)</span></p>",
      "unique_key": "Q8002091",
      "question_audio": null,
      "question_video": null,
      "map_id": 12000154,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. Fixed dose combination of drugs is preferred over single drugs</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The WHO has defined Essential Medicines (Drugs) as “those that satisfy the priority healthcare needs of the population. They are selected with due regard to public health relevance, evidence on efficacy and safety, and comparative cost effectiveness. Essential medicines are intended to be available within the context of functioning health systems at all times and in adequate amounts, in appropriate dosage forms, with assured quality and adequate information, and at a price the individual and the community can afford.”</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This is generally false. While fixed-dose combinations (FDCs) can be beneficial in certain scenarios (like in the treatment of HIV/AIDS or tuberculosis), they are not universally preferred over single-drug formulations. The preference for FDCs or single drugs depends on several factors, including the therapeutic context, the risk of drug-drug interactions, patient adherence, and the potential for resistance development. Mostly, single drugs are preferred due to their flexibility in dosing and the ability to adjust individual components based on patient needs.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Adequate safety profile needs to be established</strong>: This is true. When selecting essential drugs, it's crucial that they have a well-established safety profile. Safety is a key consideration to ensure that the benefits of a drug outweigh its risks.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Cost to benefit has to be considered</strong>: This is also true. In the selection of essential drugs, the cost-effectiveness of a drug is an important factor. The aim is to provide the most effective treatment at the lowest possible cost.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Disease prevalence is considered</strong>: This is true. When selecting essential drugs, the prevalence of diseases in a population is an important consideration. Drugs to treat common and life-threatening diseases are typically prioritized.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The selection of essential drugs prioritizes factors like safety, cost-effectiveness, and disease prevalence. Fixed-dose combinations are not universally preferred over single drugs, as the choice depends on specific therapeutic needs and other considerations.</span></p>",
      "correct_choice_id": 28170,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11805,
      "choices": [
        {
          "id": 47186,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Iloprost</span></span></p>"
        },
        {
          "id": 47187,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ambrisentan</span></span></p>"
        },
        {
          "id": 47188,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nifedipine</span></span></p>"
        },
        {
          "id": 47189,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Epoprostenol</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 35-year-old female patient with class II pulmonary hypertension presents with a negative vasoreactivity test. Which of the following is used in the next step of management? (INICET NOV 2021)</span></span></span></p>",
      "unique_key": "Q4761503",
      "question_audio": null,
      "question_video": null,
      "map_id": 12000156,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Ambrisentan</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pulmonary arterial hypertension (PAH) management depends on the results of the vasoreactivity test. In patients with a negative vasoreactivity test, calcium channel blockers such as nifedipine are not effective. Instead, treatment typically involves the use of endothelin receptor antagonists, phosphodiesterase-5 inhibitors, or prostanoids.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">For a patient with WHO functional class II PAH and a negative vasoreactivity test, the next step in management often includes endothelin receptor antagonists like Ambrisentan. Ambrisentan works by blocking the effects of endothelin-1, a potent vasoconstrictor, thereby reducing pulmonary vascular resistance and improving symptoms.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Iloprost:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Iloprost is a prostacyclin analog, used primarily in more advanced stages of PAH (class III or IV) or when other treatments have failed. It is not typically the first-line treatment for class II PAH with a negative vasoreactivity test.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Nifedipine:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Nifedipine, a calcium channel blocker, is used in patients with a positive vasoreactivity test. Since this patient has a negative vasoreactivity test, nifedipine is not appropriate.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Epoprostenol:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Epoprostenol is another prostacyclin analog used in advanced PAH (class III or IV) or refractory cases. It is not typically used for initial treatment in class II PAH with a negative vasoreactivity test.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In class II and class III pulmonary arterial hypertension (PAH), the best option is to use a combination of a phosphodiesterase inhibitor like Tadalafil and an endothelin receptor antagonist like Ambrisentan. Combination therapy is preferred, even though it may not be listed in all options. For refractory class III and class IV PAH patients, prostanoids are used.</span></span></span></p>",
      "correct_choice_id": 47187,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 56084,
      "choices": [
        {
          "id": 223761,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Opioid-induced respiratory depression</span></span></span></p>"
        },
        {
          "id": 223762,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Sedative overdose</span></span></span></p>"
        },
        {
          "id": 223763,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pulmonary embolism</span></span></span></p>"
        },
        {
          "id": 223764,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Airway obstruction</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 28-year-old man is admitted to the hospital after sustaining multiple fractures, including rib and femur fractures, following a fall from a height. To manage his severe pain, he is administered intravenous morphine. Shortly after, the patient becomes increasingly drowsy and develops shallow breathing with a significantly reduced respiratory rate. His oxygen saturation drops to 82% on room air. On examination, he is found to have pinpoint pupils and decreased responsiveness. What is the most likely cause of his respiratory distress?</span></span></span></p>",
      "unique_key": "Q4055347",
      "question_audio": null,
      "question_video": null,
      "map_id": 12000157,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<h3><span style=\"font-size:14pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"color:#434343\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ans.&nbsp;</span></span></span></strong><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A. Opioid-induced respiratory depression</span></span></strong></span></span></span></h3>\r\n\r\n<h3>&nbsp;</h3>\r\n\r\n<h3><span style=\"font-size:14pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"color:#434343\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Explanation:</span></span></span></strong></span></span></span></h3>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Opioid-induced respiratory depression is the most likely cause of this patient&#39;s respiratory distress following the administration of morphine. Opioids act on mu-opioid receptors in the brainstem, leading to suppression of the respiratory centers and resulting in decreased respiratory drive, shallow breathing, and hypoxia. The hallmark signs of opioid toxicity include pinpoint pupils, decreased respiratory rate, and altered mental status. Early recognition and treatment with naloxone, an opioid antagonist, are crucial to rapidly reverse respiratory depression and restore normal breathing.</span></span></span></p>\r\n\r\n<h3>&nbsp;</h3>\r\n\r\n<h3><span style=\"font-size:14pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"color:#434343\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Other Options:</span></span></span></strong></span></span></span></h3>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">B. Sedative overdose:&nbsp;</span></strong><span style=\"font-size:12.0pt\">This option is incorrect because the presentation is more specific to opioid toxicity rather than a general sedative effect. While sedatives can cause respiratory depression, pinpoint pupils are characteristic of opioid overdose.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">C. Pulmonary embolism:&nbsp;</span></strong><span style=\"font-size:12.0pt\">This option is incorrect as pulmonary embolism typically presents with sudden-onset dyspnea, pleuritic chest pain, and tachycardia. The immediate link to opioid administration and presence of pinpoint pupils make opioid-induced depression more likely.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">D. Airway obstruction:&nbsp;</span></strong><span style=\"font-size:12.0pt\">This is incorrect because airway obstruction usually presents with stridor, wheezing, or evidence of choking. The pinpoint pupils and shallow breathing following opioid administration indicate a central cause rather than an obstructive one.</span></span></span></p>\r\n\r\n<h3>&nbsp;</h3>\r\n\r\n<h3><span style=\"font-size:14pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"color:#434343\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Educational Objective:</span></span></span></strong></span></span></span></h3>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Opioid-induced respiratory depression is a critical side effect of opioid medications due to their central action on respiratory centers. Recognizing signs such as decreased respiratory rate, pinpoint pupils, and altered consciousness is vital for prompt administration of naloxone, which can quickly reverse opioid toxicity and prevent further respiratory compromise.</span></span></span></p>",
      "correct_choice_id": 223761,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14339,
      "choices": [
        {
          "id": 57317,
          "text": "<p><span style=\"font-size:12.0pt;\">Advanced gastric carcinoma</span></p>"
        },
        {
          "id": 57318,
          "text": "<p><span style=\"font-size:12.0pt;\">Gallbladder carcinoma</span></p>"
        },
        {
          "id": 57319,
          "text": "<p><span style=\"font-size:12.0pt;\">Distal cholangiocarcinoma</span></p>"
        },
        {
          "id": 57320,
          "text": "<p><span style=\"font-size:12.0pt;\">Chronic calcific pancreatitis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The following procedure is performed for the management of:</span><span style=\"font-size:11.0pt;\"> (</span><span style=\"font-size:12.0pt;\">INICET MAY 2022)</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/06/untitled-648.jpg\" alt=\"\" width=\"400\" height=\"296\"></span></p>",
      "unique_key": "Q7964501",
      "question_audio": null,
      "question_video": null,
      "map_id": 12000488,
      "difficulty_level": "beginner",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Distal cholangiocarcinoma</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>The image shown is of Whipple’s procedure, which can be done for distal cholangiocarcinoma.</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Whipple's procedure, also known as pancreaticoduodenectomy, is a complex surgical procedure that involves removing the head of the pancreas, the duodenum, a portion of the common bile duct, the gallbladder, and sometimes a portion of the stomach.</span></li><li><span style=\"font-size:12.0pt;\">This procedure is typically performed to treat cancer of the pancreas, duodenum, or the ampulla of Vater</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Distal cholangiocarcinoma is cancer that occurs in the bile ducts, typically in the lower part of the bile duct near the pancreas. The procedure referred to in the question is often associated with the surgical management of distal cholangiocarcinoma. It involves a Whipple procedure (pancreaticoduodenectomy), which is a complex surgical procedure to remove the affected part of the bile duct, pancreas, and small intestine, and then reconstruct the digestive tract.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Advanced gastric carcinoma</strong>: The management of advanced gastric carcinoma typically involves various approaches, including surgery, chemotherapy, and radiation therapy. Surgical procedures such as gastrectomy or lymphadenectomy may be performed depending on the stage and location of the tumor.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Gallbladder carcinoma</strong>: Gallbladder carcinoma may be treated with surgical resection, often involving cholecystectomy (removal of the gallbladder) and potentially more extensive procedures if the cancer has spread. However, the procedure mentioned in the question is not specific to gallbladder carcinoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Chronic calcific pancreatitis</strong>: Chronic calcific pancreatitis may require surgical intervention in certain cases, but the procedure mentioned in the question is not specific to this condition. Surgical options for chronic pancreatitis may include drainage procedures or resection of the affected pancreatic tissue.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span><br>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The procedure mentioned in the question, which is often performed to manage distal cholangiocarcinoma, is a Whipple procedure (pancreaticoduodenectomy).</span></p>",
      "correct_choice_id": 57319,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7155,
      "choices": [
        {
          "id": 28588,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A-1, B-3, C-2, D-4</span></span></span></span></span></p>"
        },
        {
          "id": 28589,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\">﻿﻿﻿<span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A-4, B-1, C-3, D-2</span></span></span></span></span></p>"
        },
        {
          "id": 28590,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">﻿﻿﻿A-2, B-4, C-1, D-3</span></span></span></span></span></p>"
        },
        {
          "id": 28591,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A-3, B-2, C-4, D-1</span></span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-family:Helvetica\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Match the following drugs in Column A with their contraindications in Column B? (INICET NOV 2022)</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Helvetica\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/01/screenshot-2023-12-01-180006.jpg\" style=\"height:312px; width:700px\" /></span></span></span></p>",
      "unique_key": "Q8737841",
      "question_audio": null,
      "question_video": null,
      "map_id": 12000489,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. <span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A-4, B-1, C-3, D-2</span></strong></span></span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Morphine is contraindicated in head injury due to the following reasons:</span></span></strong></span></span></span>\r\n\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It causes miosis and in patients with head injury who are in a comatose state, the progress of the patient after giving drugs is assessed by pupillary reaction. So, if the pupil already remains constricted due to morphine, the assessment of progress cannot be done.</span></span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Morphine leads to respiratory depression and if in the patients with head injury, if the respiratory rate is already depressed, it will get aggravated.</span></span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Respiratory depression will lead to accumulation of CO2, leading to vasodilatation and increased intracranial pressure.</span></span></span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Amiodarone can cause QT prolongation and even precipitate Torsade de pointes.</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vigabatrin is contraindicated in pregnancy as it is teratogenic.</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Estrogen preparations are known to increase the risk of thromboembolism.</span></span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica\"><span style=\"font-family:Helvetica\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Morphine is contraindicated in head injury due to its effects on pupil size and respiratory depression. Amiodarone is associated with QT prolongation and potential arrhythmias. Vigabatrin is teratogenic and contraindicated in pregnancy. Estrogen increases the risk of thromboembolic events.</span></span></span></span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 28589,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6460,
      "choices": [
        {
          "id": 25809,
          "text": "<p><span style=\"font-size:12.0pt;\">C is competitive antagonist</span></p>"
        },
        {
          "id": 25810,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿C is more potent than A</span></p>"
        },
        {
          "id": 25811,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿B is more potent than A</span></p>"
        },
        {
          "id": 25812,
          "text": "<p><span style=\"font-size:12.0pt;\">B is competitive antagonist</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following statements is true regarding the dose-response curve shown in the image below?</span> <span style=\"font-size:12.0pt;\">(NEET PG 2019)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/03/204.jpg\" alt=\"\" width=\"400\" height=\"267\"></span></p>",
      "unique_key": "Q2956008",
      "question_audio": null,
      "question_video": null,
      "map_id": 12000490,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) B is competitive antagonist</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This questions tests the knowledge regarding two different things about dose response curve:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">a. Potency and Efficacy: Remember, to take HELP whenever in doubt. It means Height of the curve tells about Efficacy (higher the curve, the more efficacious the drug is) and Left sidedness of the curve tells about Potency (Drugs with curves on left side are more potent than drugs with curve on right side)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">b. Type of Inhibition: If the curve shifts parallelly to right, the drug is a competitive inhibitor, if it shifts down, the drug is a non-competitive inhibitor.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>What is given in graph:&nbsp;</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The DRC of drug B has shifted to the right of the DRC of drug A , although the height of the two curves is the same. On the other hand, Drug C has shifted the curve down.</span></li><li><span style=\"font-size:12.0pt;\">Further height of curve in Drug A and B is same but more than Drug C.</span></li><li><span style=\"font-size:12.0pt;\">Curve of Drug A is on most left followed by Drug C and then Drug B.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Inferences:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Therefore, the following inferences can be drawn from the given image:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The efficacy of Drug A = Drug B &gt; Drug C</span></li><li><span style=\"font-size:12.0pt;\">The Potency of Drug A &gt; Drug C &gt; Drug B</span></li><li><span style=\"font-size:12.0pt;\">Drug B is a competitive inhibitor of Drug A</span></li><li><span style=\"font-size:12.0pt;\">Drug C is a non-competitive inhibitor of Drug A</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Efficacy</strong>: The height of the curve represents the efficacy of the drug. The higher the curve, the more efficacious the drug.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Potency</strong>: The position of the curve along the x-axis (left or right) indicates the potency. Drugs with curves on the left side are more potent than those on the right side.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Type of Inhibition</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Competitive Inhibition</strong>: A competitive inhibitor will shift the dose-response curve to the right without changing the maximum effect (efficacy). This indicates that higher concentrations of the agonist can overcome the inhibition.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Non-Competitive Inhibition</strong>: A non-competitive inhibitor will reduce the maximum effect (efficacy) of the agonist, causing a downward shift in the dose-response curve.</span></li></ul>",
      "correct_choice_id": 25812,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7081,
      "choices": [
        {
          "id": 28292,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Tmax</span></span></span></p>"
        },
        {
          "id": 28293,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Area under the curve</span></span></span></p>"
        },
        {
          "id": 28294,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cmax</span></span></span></p>"
        },
        {
          "id": 28295,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">t1/2</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The extent of drug absorption in plasma concentration vs time graph is represented by:</span></span>(INICET MAY 2022)</p>",
      "unique_key": "Q4893792",
      "question_audio": null,
      "question_video": null,
      "map_id": 12000491,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B. Area under the curve</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Area under the curve (AUC) is a measure of the total drug exposure in the bloodstream over time. It reflects the total amount of drug absorbed and is often used to assess the overall bioavailability of a drug. AUC is crucial for determining the efficacy and safety of a medication.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Tmax (Time to Maximum Concentration):</span></strong><span style=\"font-size:12.0pt\"> Tmax represents the time it takes for a drug to reach its maximum concentration (Cmax) in the bloodstream. It tells about rate of drug absorption. </span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Cmax (Maximum Concentration):</span></strong><span style=\"font-size:12.0pt\"> Cmax represents the highest concentration of a drug in the bloodstream after administration. This parameter is important because it indicates the peak therapeutic effect and helps assess the risk of side effects associated with high drug concentrations.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. t1/2 (Half-Life):</span></strong><span style=\"font-size:12.0pt\"> t1/2 is the time it takes for half of the drug to be eliminated from the bloodstream. It is not directly related to drug absorption but is essential in understanding how long a drug remains in the body and how often it needs to be administered.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The Area Under the Curve (AUC) in a plasma concentration vs. time graph represents the extent of drug absorption, reflecting the total drug exposure over time and the overall bioavailability of the drug.</span></span></span></p>",
      "correct_choice_id": 28293,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3460,
      "choices": [
        {
          "id": 13819,
          "text": "<p><span style=\"font-size:12.0pt;\">Echinococcus granulosus</span></p>"
        },
        {
          "id": 13820,
          "text": "<p><span style=\"font-size:12.0pt;\">Schistosoma japonicum</span></p>"
        },
        {
          "id": 13821,
          "text": "<p><span style=\"font-size:12.0pt;\">Trypanosoma cruzi</span></p>"
        },
        {
          "id": 13822,
          "text": "<p><span style=\"font-size:12.0pt;\">Schistosoma mansoni</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the causative organism for the condition shown in the image below?</span><span style=\"font-size:10.5pt;\"> (</span><span style=\"font-size:12.0pt;\">INICET MAY 2020)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/30/untitled-256.jpg\" alt=\"\" width=\"300\" height=\"300\"></span></p>",
      "unique_key": "Q4996812",
      "question_audio": null,
      "question_video": null,
      "map_id": 12000492,
      "difficulty_level": "beginner",
      "subjects_id": [
        6
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Echinococcus granulosus</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The given image shows a hydatid cyst in the liver. Large, unilocular/multilocular, well-defined, hypodense cysts. Contains multiple internal “daughter” cysts of lower density than “mother” cyst (exocyst). Curvilinear ring-like calcification of pericyst (wall).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Causative organism – Echinococcus granulosus</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Definitive hosts – Dogs, Intermediate host – Sheep, Accidental intermediate host – Human</strong> (end stage host)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In the liver, the pressure effect of the cyst can produce symptoms of <u>obstructive jaundice</u> and abdominal pain. <u>With biliary rupture, the classic triad of biliary colic, jaundice, and urticaria</u> is observed. Passage of hydatid membranes in the emesis (hydatid emesia) and passage of membranes in the stools (hydatid enterica) may occur rarely.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/30/1-micro-26.jpg\" alt=\"\" width=\"700\" height=\"514\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Schistosoma japonicum</strong>: This parasitic worm causes schistosomiasis, primarily affecting the intestines and liver, but it does not form hydatid cysts.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Trypanosoma cruzi</strong>: This protozoan parasite causes Chagas disease, which primarily affects the heart and digestive system, not forming cysts in the liver.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Schistosoma mansoni</strong>: This parasitic worm also causes schistosomiasis, affecting the intestines and liver, but it does not form hydatid cysts.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The condition shown in the image, characterized by a hydatid cyst in the liver, is caused by Echinococcus granulosus. The cysts contain internal daughter cysts and can lead to symptoms related to the pressure effect on the liver and biliary system.</span></p>",
      "correct_choice_id": 13819,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2019,
      "choices": [
        {
          "id": 8069,
          "text": "<p><span style=\"font-size:12.0pt;\">Glucose</span></p>"
        },
        {
          "id": 8070,
          "text": "<p><span style=\"font-size:12.0pt;\">Ketones</span></p>"
        },
        {
          "id": 8071,
          "text": "<p><span style=\"font-size:12.0pt;\">Amino acids</span></p>"
        },
        {
          "id": 8072,
          "text": "<p><span style=\"font-size:12.0pt;\">Fatty Acid</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">RBC uses which of the following substances during fasting/starvation? (INICET MAY 2021)</span></p>",
      "unique_key": "Q7356838",
      "question_audio": null,
      "question_video": null,
      "map_id": 12000493,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Glucose</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Under normal physiological conditions, RBCs rely on glucose as their main energy source. Glucose is metabolized through the glycolytic pathway within RBCs to produce ATP, which is essential for maintaining the structural and functional integrity of red blood cells. RBCs lack mitochondria, so they exclusively use anaerobic glycolysis to generate energy from glucose.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B</strong>.&nbsp;<strong>Ketones:</strong> RBCs do not utilize ketones as a significant energy source. Ketones are typically used by other tissues like the brain and muscles during prolonged fasting or starvation when glucose levels are low.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C</strong>.&nbsp;<strong>Amino acids:</strong> While amino acids can be used as an energy source by some tissues during fasting or starvation, RBCs primarily rely on glucose and do not extensively use amino acids for energy production.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Fatty acids:</strong> RBCs do not use fatty acids as their primary energy source during fasting or starvation. Fatty acid metabolism primarily occurs in tissues with mitochondria, and RBCs lack these organelles.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">RBCs always uses glucose whether it is fed state or fasting/starvation state because RBCs lack mitochondria. As ketone body utilization and fatty acid oxidation both take place in mitochondria so, RBCs cannot use fatty acids &amp; ketone bodies as energy source.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Table: Substrates utilized for energy production</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/04/screenshot-2024-06-04-105602_4CNXu8b.jpg\" alt=\"\" width=\"1000\" height=\"446\"></strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Fetal heart and also in case of heart failure, main fuel is Glucose.</span></li><li><span style=\"font-size:12.0pt;\">Brain cannot use FA as FAs cannot cross blood brain barrier.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><i><strong>Ref-Harper 31<sup>st</sup> e/p 138-139</strong></i></span></p>",
      "correct_choice_id": 8069,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7034,
      "choices": [
        {
          "id": 28104,
          "text": "<p><span style=\"font-size:12pt;\">Protects the acid labile drug from gastric acidity</span></p>"
        },
        {
          "id": 28105,
          "text": "<p><span style=\"font-size:12pt;\">Protects the gastric mucosa from irritant effects of certain drugs</span></p>"
        },
        {
          "id": 28106,
          "text": "<p><span style=\"font-size:12pt;\">Prolongs the half-life of the drug</span></p>"
        },
        {
          "id": 28107,
          "text": "<p><span style=\"font-size:12pt;\">Delivers drugs distal to stomach</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Many drugs are given as enteric coated tablets. All of the following are the advantages of enteric coating of drugs EXCEPT? (AIIMS MAY 2020)</span><br>&nbsp;</p>",
      "unique_key": "Q6458337",
      "question_audio": null,
      "question_video": null,
      "map_id": 12000494,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C. Prolongs the half-life of the drug</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Enteric coatings on tablets protect acid-labile drugs from gastric acidity, protect the gastric mucosa from irritant effects, and deliver drugs distal to the stomach. However, they do not prolong the half-life of a drug, which is determined by the drug's metabolism and elimination from the body.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Enteric-coated drugs are designed with a special coating that resists dissolution in the acidic environment of the stomach. This coating dissolves instead in the more alkaline environment of the small intestine. The primary purposes of this enteric coating are:</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Protect the acid-labile drug from gastric acidity:&nbsp;</strong>Some drugs are unstable in the acidic environment of the stomach and can be degraded before they have a chance to be absorbed. Enteric coating protects these drugs from the acidic gastric environment, ensuring they reach the intestine, where they can be absorbed effectively.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Protect the gastric mucosa from the irritant effects of certain drugs:&nbsp;</strong>Certain drugs can irritate the gastric mucosa, leading to discomfort or even ulcers. Enteric coating prevents these drugs from being released in the stomach, thereby reducing the risk of gastric irritation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Deliver drugs distal to the stomach:&nbsp;</strong>Enteric coating is also used to ensure that a drug is released in the intestine rather than the stomach, which can be important for drugs that are intended to act in the intestine or are better absorbed from the intestinal lining.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Enteric coating is primarily used to protect acid-labile drugs from gastric acidity, protect the gastric mucosa from irritant effects, and ensure drug delivery distal to the stomach. It does not prolong the half-life of the drug.</span></p>",
      "correct_choice_id": 28106,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7122,
      "choices": [
        {
          "id": 28456,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Causes monofollicular development</span></span></span></p>"
        },
        {
          "id": 28457,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Inhibits negative feedback on GnRH</span></span></span></p>"
        },
        {
          "id": 28458,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Causes endometrial thinning</span></span></span></p>"
        },
        {
          "id": 28459,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Can be used with gonadotropins</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is the incorrect statement regarding clomiphene citrate? (INICET MAY 2021)</span></span></p>",
      "unique_key": "Q6177632",
      "question_audio": null,
      "question_video": null,
      "map_id": 12000495,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A. Causes monofollicular development</span></strong></span></span><br />\r\n&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Clomiphene citrate is SERM (Selective Estrogen Receptor Modulator) that inhibits the negative feedback of estrogen on the hypothalamus, which in turn leads to an increase in LH/FSH, and this helps in the development of multiple follicles in the ovary. Clomiphene is used in the treatment of anovulatory infertility.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Due to its anti-estrogenic action over the endometrium, it causes thickening of the cervical mucus and thinning of the endometrium.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Sometimes for ovulation induction, gonadotropins can be used with clomiphene, but it has a risk of giving rise to multiple pregnancy.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Inhibits negative feedback on GnRH: </span></strong><span style=\"font-size:12.0pt\">This statement is correct. Clomiphene citrate inhibits the negative feedback of estrogen on the hypothalamus, which increases the release of GnRH, and subsequently increases LH and FSH secretion from the pituitary gland.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Causes endometrial thinning: </span></strong><span style=\"font-size:12.0pt\">This statement is correct. Clomiphene citrate has an anti-estrogenic effect on the endometrium, which can lead to thinning of the endometrial lining, potentially impacting embryo implantation.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Can be used with gonadotropins: </span></strong><span style=\"font-size:12.0pt\">This statement is correct. Clomiphene can be used in combination with gonadotropins for ovulation induction, but this approach increases the risk of multiple pregnancies due to the stimulation of multiple follicles.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Clomiphene citrate induces ovulation by inhibiting the negative feedback of estrogen on the hypothalamus, leading to increased secretion of gonadotropins and the development of multiple follicles. It can cause endometrial thinning and can be used with gonadotropins, but it does not cause monofollicular development.</span></span></span></p>",
      "correct_choice_id": 28456,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6865,
      "choices": [
        {
          "id": 27428,
          "text": "<p><span style=\"font-size:12.0pt;\">Na, K</span></p>"
        },
        {
          "id": 27429,
          "text": "<p><span style=\"font-size:12.0pt;\">K. Na</span></p>"
        },
        {
          "id": 27430,
          "text": "<p><span style=\"font-size:12.0pt;\">Na, Ca</span></p>"
        },
        {
          "id": 27431,
          "text": "<p><span style=\"font-size:12.0pt;\">Ca, Na</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the ions A and B based on conductance graph of a neuron shown below: (AIIMS NOV 2018)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img class=\"image_resized\" style=\"aspect-ratio:762/402;width:71.55%;\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Untitled%20design_YAq0N71.png\" width=\"762\" height=\"402\"></span></p>",
      "unique_key": "Q8738391",
      "question_audio": null,
      "question_video": null,
      "map_id": 12000496,
      "difficulty_level": "beginner",
      "subjects_id": [
        2
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Na, K</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Channel A:</strong> Na+, Channel B: K+</span><br><br><span style=\"font-size:12.0pt;\"><img class=\"image_resized\" style=\"aspect-ratio:781/409;width:70.52%;\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_smwfi82.png\" width=\"781\" height=\"409\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">During the early portion of the action potential, the ratio of sodium to potassium conductance increases more than 1000-fold. Therefore, far more sodium ions flow to the interior of the fiber than do potassium ions to the exterior. This causes the membrane potential to become positive at the action potential onset.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Then the sodium channels begin to close and the potassium channels to open, so that the ratio of conductance shifts far in favor of high potassium conductance but low sodium conductance. This allows very rapid loss of potassium ions to the exterior but virtually zero flow of sodium ions to the interior.</span></p><p><span style=\"font-size:12.0pt;\">Consequently, the action potential quickly returns to its baseline level.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">During an action potential, sodium conductance increases first (Channel A), followed by an increase in potassium conductance (Channel B), causing depolarization and subsequent repolarization of the neuron.</span></p>",
      "correct_choice_id": 27428,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 31809,
      "choices": [
        {
          "id": 127106,
          "text": "<p><span style=\"font-size:12pt;\">Cycloserine</span></p>"
        },
        {
          "id": 127107,
          "text": "<p><span style=\"font-size:12pt;\">Ethionamide</span></p>"
        },
        {
          "id": 127108,
          "text": "<p><span style=\"font-size:12pt;\">Streptomycin</span></p>"
        },
        {
          "id": 127109,
          "text": "<p><span style=\"font-size:12pt;\">Pyrazinamide</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A young patient undergoing treatment for multidrug-resistant tuberculosis (MDR-TB) presents with symptoms of weight gain, cold intolerance, and lethargy. Laboratory investigations reveal high levels of thyroid-stimulating hormone (TSH) and low levels of T3 (triiodothyronine) and T4 (thyroxine). Which of the following drugs is likely responsible for these symptoms? (INICET NOV 2023)</span></p>",
      "unique_key": "Q8481746",
      "question_audio": null,
      "question_video": null,
      "map_id": 12000497,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Ethionamide.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Ethionamide, a second-line antitubercular agent used in the treatment of MDR-TB, is known to cause hypothyroidism as a side effect. This condition is characterized by an underactive thyroid gland, leading to symptoms such as weight gain, cold intolerance, and lethargy. The laboratory findings of elevated TSH and low levels of T3 and T4 further support this diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Cycloserine:</strong> Cycloserine is used in the treatment of MDR-TB, but its side effects are more commonly neurological, including mood changes and seizures. It is not typically associated with thyroid dysfunction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Streptomycin:</strong> Streptomycin, an aminoglycoside antibiotic, is used in TB treatment and is known for its potential ototoxicity and nephrotoxicity, rather than effects on thyroid function.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Pyrazinamide:</strong> Pyrazinamide is a first-line anti-TB medication. Its side effects include hepatotoxicity and hyperuricemia but not typically hypothyroidism.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Ethionamide, a second-line drug used in the treatment of multidrug-resistant tuberculosis (MDR-TB), can cause hypothyroidism, characterized by symptoms such as weight gain, cold intolerance, lethargy, elevated TSH, and low T3 and T4 levels.</span></p>",
      "correct_choice_id": 127107,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3687,
      "choices": [
        {
          "id": 14727,
          "text": "<p><span style=\"font-size:12.0pt;\">Botulinum</span></p>"
        },
        {
          "id": 14728,
          "text": "<p><span style=\"font-size:12.0pt;\">Tetanus</span></p>"
        },
        {
          "id": 14729,
          "text": "<p><span style=\"font-size:12.0pt;\">Diphtheria</span></p>"
        },
        {
          "id": 14730,
          "text": "<p><span style=\"font-size:12.0pt;\">Pertussis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which toxin acts via the mechanism depicted in the image below? (INICET NOV 2019)</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/01/screenshot-2024-07-01-110223.png\" alt=\"\" width=\"500\" height=\"348\"></p>",
      "unique_key": "Q1582642",
      "question_audio": null,
      "question_video": null,
      "map_id": 12000498,
      "difficulty_level": "beginner",
      "subjects_id": [
        6
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Botulinum</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The image given above depicts the mechanism of action of botulinum toxin.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Clostridium botulinum is <u>non-invasive</u>. Its pathogenesis is due to the production of powerful neurotoxin ‘botulinum toxin’ (BoNT). It produces <strong>flaccid paralysis</strong>. There are 7 serological types of botulinum neurotoxin labeled as types A, B, C [C1 C2], D, E, F, and G. Human botulism is caused mainly by types A, B, E and F (rarely).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">After entry (either <strong>ingested, inhaled, or produced </strong>in a wound), botulinum toxin is transported via the <u>blood to peripheral cholinergic nerve terminals</u>. The most common nerve terminal sites are neuromuscular junctions, postganglionic parasympathetic nerve endings, and peripheral ganglia. <strong>It does not affect the CNS.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Botulinum toxin causes <strong>proteolysis of snare proteins</strong> that are required for the excocytosis of acetylcholine vesicles, thereby <strong>preventing the release of acetylcholine (Ach) at the peripheral nerve endings, including neuromuscular junctions (presynaptic inhibition</strong>). This results in a lack of stimulus to the muscle fibers, irreversible relaxation of the muscles to presynaptic inhibition of neuronal, and flaccid paralysis.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/01/screenshot-2024-07-01-110414.png\" alt=\"\" width=\"500\" height=\"227\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Tetanus:</strong> Tetanus toxin (produced by Clostridium tetani) acts by inhibiting neurotransmitter release in the central nervous system by cleaving synaptobrevin, another SNARE protein, but it causes spastic paralysis rather than flaccid paralysis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Diphtheria:</strong> Diphtheria toxin (produced by Corynebacterium diphtheriae) inhibits protein synthesis in host cells by ADP-ribosylation of elongation factor-2 (EF-2), which is a completely different mechanism from that of botulinum toxin.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Pertussis:</strong> Pertussis toxin (produced by Bordetella pertussis) modifies the signaling of G-protein coupled receptors by ADP-ribosylating the Gi protein, thereby affecting cellular communication but not directly impacting acetylcholine release at neuromuscular junctions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Botulinum toxin causes flaccid paralysis by preventing the release of acetylcholine at peripheral nerve endings through the proteolysis of SNARE proteins necessary for acetylcholine vesicle exocytosis.</span></p>",
      "correct_choice_id": 14727,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7150,
      "choices": [
        {
          "id": 28568,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Beta blockers</span></span></span></p>"
        },
        {
          "id": 28569,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Calcium channel blockers</span></span></span></p>"
        },
        {
          "id": 28570,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acetaminophen</span></span></span></p>"
        },
        {
          "id": 28571,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Aspirin</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Urinary alkalinization will be most useful in toxicity of which of the following drugs? (INICET NOV 2020)</span></span></p>",
      "unique_key": "Q3639351",
      "question_audio": null,
      "question_video": null,
      "map_id": 12000499,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D. Aspirin</span></strong></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Urinary alkalinization is a key treatment in aspirin toxicity. Aspirin (salicylate) is a weak acid, and alkalinizing the urine increases the ionization of salicylates. This ionization traps salicylates in the urine, preventing their reabsorption and enhancing their elimination.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Beta blockers:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Urinary alkalinization is not a standard treatment for beta blocker toxicity. Management of beta blocker overdose typically involves supportive care and, in severe cases, specific antidotes like glucagon or high-dose insulin.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Calcium channel blockers:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Similar to beta blockers, urinary alkalinization is not a primary treatment for calcium channel blocker overdose. Treatment often includes calcium infusions, glucagon, and other supportive measures.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Acetaminophen:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> For acetaminophen toxicity, the antidote N-acetylcysteine (NAC) is used. Urinary alkalinization is not effective for acetaminophen overdose.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Urinary alkalinization is most useful in the treatment of aspirin (salicylate) toxicity because it increases the elimination of salicylates by trapping them in the urine through ionization. This method is not effective for beta blockers, calcium channel blockers, or acetaminophen toxicity.</span></span></span></p>",
      "correct_choice_id": 28571,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6903,
      "choices": [
        {
          "id": 27580,
          "text": "<p><span style=\"font-size:12.0pt;\">1:10000 I.V. - 10 ml</span></p>"
        },
        {
          "id": 27581,
          "text": "<p><span style=\"font-size:12.0pt;\">1:1000 I.M. - 0.5 ml</span></p>"
        },
        {
          "id": 27582,
          "text": "<p><span style=\"font-size:12.0pt;\">1:1000 I.M. - 1 ml</span></p>"
        },
        {
          "id": 27583,
          "text": "<p><span style=\"font-size:12.0pt;\">1:1000 I.V. - 0.5 ml</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">What dose of epinephrine is used in anaphylactic shock? (AIIMS NOV 2019)</span></p>",
      "unique_key": "Q5093771",
      "question_audio": null,
      "question_video": null,
      "map_id": 12000500,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. 1:1000 I.M. - 0.5 ml</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Epinephrine (1:1000 solution) 0.5 ml via intramuscular route is preferred in the treatment of anaphylactic shock.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/20/screenshot-2023-12-20-103204.jpg\" alt=\"\" width=\"1000\" height=\"398\"></span></p>",
      "correct_choice_id": 27581,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6961,
      "choices": [
        {
          "id": 27812,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">5-HT antagonist </span></span></span></p>"
        },
        {
          "id": 27813,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">5-HT agonist</span></span></span></p>"
        },
        {
          "id": 27814,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Calcium Channel Blocker action</span></span></span></p>"
        },
        {
          "id": 27815,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nitric oxide mediated vasodilation</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">An elderly woman on treatment for migraine presents with chest pain. She has a previous history of ischemic heart disease. Which of the following mechanism of the prescribed drug for migraine might have caused this presentation? (INICET NOV 2020)</span></span></p>",
      "unique_key": "Q1802971",
      "question_audio": null,
      "question_video": null,
      "map_id": 12000501,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. 5-HT agonist</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chest pain in an elderly woman with a history of ischemic heart disease, who is on treatment for migraine, could potentially be linked to the mechanism of action of her migraine medication. Among the options given 5-HT agonists can cause this adverse effect. Triptans and ergotamine are a group of drugs that are used in acute attacks of migraine. They act on 5HT1B/1D receptors as agonist and cause vasoconstriction of the blood vessels. Therefore, they should be avoided in patients with coronary artery disease as they can precipitate myocardial infarction.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>5-HT Antagonist</strong>: Serotonin (5-HT) antagonists like cyproheptadine and methysergide etc are used for prophylaxis of migraine (not in treatment). These drugs are not commonly associated with causing chest pain or exacerbating ischemic heart disease.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Calcium Channel Blocker Action</strong>: While calcium channel blockers (CCBs) are used in migraine prophylaxis, they are generally heart-protective and used in the treatment of angina and hypertension due to their vasodilatory effects. It&#39;s unlikely that CCBs would cause chest pain.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Nitric Oxide Mediated Vasodilation</strong>: Nitric oxide donors (like nitrates) are used in the treatment of angina due to their vasodilatory effects. They are not typically used in migraine treatment, and their vasodilatory action would be more likely to relieve, rather than cause, ischemic chest pain.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">5-HT Agonist</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> includes medications like triptans (e.g., sumatriptan), which are commonly used in migraine treatment. Triptans are 5-HT1B/1D receptor agonists and can cause vasoconstriction of blood vessels. In patients with ischemic heart disease, this vasoconstriction can exacerbate angina (chest pain) or precipitate myocardial infarction, especially if the coronary arteries are already compromised.</span></span></span></p>",
      "correct_choice_id": 27813,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14050,
      "choices": [
        {
          "id": 56161,
          "text": "<p><span style=\"font-size:12.0pt;\">Dermatofibrosarcoma</span></p>"
        },
        {
          "id": 56162,
          "text": "<p><span style=\"font-size:12.0pt;\">Marjolin's ulcer</span></p>"
        },
        {
          "id": 56163,
          "text": "<p><span style=\"font-size:12.0pt;\">ВСС&nbsp;(Basal cell carcinoma)</span></p>"
        },
        {
          "id": 56164,
          "text": "<p><span style=\"font-size:12.0pt;\">Naevus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 65-year-old man has a lesion over the face as shown below. He complains of bleeding while itching. The most likely diagnosis is: (AIIMS NOV 2017)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/04/untitled-181.jpg\" alt=\"\" width=\"250\" height=\"297\"></span></p>",
      "unique_key": "Q1419263",
      "question_audio": null,
      "question_video": null,
      "map_id": 12000502,
      "difficulty_level": "beginner",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) BCC (Basal cell carcinoma)</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The given history with the image showing an ulcer over the face with pearly, rolled-out borders points to a diagnosis of basal cell carcinoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Basal cell carcinoma is the most common type of skin cancer, especially in older individuals with sun exposure. It often appears as a pearly or waxy bump with central depression, which can bleed easily. Itching is also a common symptom associated with BCC.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>A. Dermatofibrosarcoma</strong>: Dermatofibrosarcoma is a rare, slow-growing soft tissue tumor that typically presents as a painless, raised, flesh-colored or brownish lesion. It does not commonly cause bleeding or itching.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/01/picture7_FOMXyQg.jpg\" alt=\"\" width=\"400\" height=\"231\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Marjolin's Ulcer</strong>: Marjolin's ulcer refers to a malignant transformation of a chronic non-healing wound, scar, or ulcer. It is often associated with long-standing inflammation or trauma. While it can present with bleeding, it typically doesn't cause itching as a primary symptom.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/01/whatsapp-image-2023-12-01-at-42006-pm-2.jpeg\" alt=\"\" width=\"400\" height=\"247\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Naevus</strong>: A nevus, commonly known as a mole, is a benign skin lesion. While moles can occasionally be itchy, they do not usually cause bleeding unless they are irritated or traumatized.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Basal cell carcinoma is an epithelial tumor that arises from basal cells layer of epidermis. It is the most common type of skin cancer. Most commonly seen over the face, above the line joining corner of the mouth, and lobule of the ear. Clinically it can present either as nodular or pigmented BCC. Features of nodular BCC are:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Small, slowly growing pearly nodule</span></li><li><span style=\"font-size:12.0pt;\">Tortuous telangiectatic vessels on the surface</span></li><li><span style=\"font-size:12.0pt;\">Rolled borders</span></li><li><span style=\"font-size:12.0pt;\">Central crusting</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The occasional presence of melanin in the nodular variant of BCC (pigmented BCC) may lead to confusion with melanoma.</span></p>",
      "correct_choice_id": 56163,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6970,
      "choices": [
        {
          "id": 27848,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">TDM is done with penicillin because of narrow therapeutic index</span></span></span></p>"
        },
        {
          "id": 27849,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">TDM is done with gentamicin because of narrow therapeutic index</span></span></span></p>"
        },
        {
          "id": 27850,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">TDM is done with both because of dangerous side effects</span></span></span></p>"
        },
        {
          "id": 27851,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Both drugs do not need monitoring</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following statements is correct for a patient on high dose of penicillin and gentamicin? iNICET NOV 2020)</span></span></p>",
      "unique_key": "Q6922280",
      "question_audio": null,
      "question_video": null,
      "map_id": 12000503,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. TDM is done with gentamicin because of narrow therapeutic index</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Therapeutic Drug Monitoring has to be done for drugs that have a narrow safety margin. Gentamicin is an aminoglycoside antibiotic that acts by inhibiting the protein synthesis at the 30S ribosomal subunit of the bacteria. It is nephrotoxic as well as ototoxic. It has a narrow therapeutic margin; therefore, it requires TDM.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B.</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>TDM is done with gentamicin because of narrow therapeutic index</strong>: Gentamicin is an aminoglycoside antibiotic, and these drugs are known for their narrow therapeutic index. TDM is important for gentamicin to ensure effective therapeutic levels are achieved without causing toxicity. Aminoglycosides can cause nephrotoxicity (kidney damage) and ototoxicity (hearing loss), so monitoring blood levels is crucial to avoid these adverse effects.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Options A.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>TDM is done with penicillin because of narrow therapeutic index</strong>: This is not typically the case. Penicillin, for the most part, does not have a narrow therapeutic index, and Therapeutic Drug Monitoring (TDM) is generally not required for penicillin.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Options C.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>TDM is done with both because of dangerous side effects</strong>: While it&#39;s true that both drugs can have side effects, TDM is generally only recommended for gentamicin because of its narrow therapeutic window and potential for serious side effects. Penicillin does not typically require TDM.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Options D.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Both drugs do not need monitoring</strong>: This statement is incorrect because gentamicin does require monitoring due to its narrow therapeutic index and potential for toxicity.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Therapeutic Drug Monitoring (TDM) is crucial for gentamicin due to its narrow therapeutic index and potential for nephrotoxicity and ototoxicity. Penicillin, on the other hand, generally does not require TDM because it does not have a narrow therapeutic index.</span></span></span></p>",
      "correct_choice_id": 27849,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6927,
      "choices": [
        {
          "id": 27676,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Primaquine</span></span></span></p>"
        },
        {
          "id": 27677,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Chloroquine</span></span></span></p>"
        },
        {
          "id": 27678,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Quinine</span></span></span></p>"
        },
        {
          "id": 27679,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">D None</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is gametocidal to all the species causing malaria? (AIIMS NOV 2018)</span></span></p>",
      "unique_key": "Q8283134",
      "question_audio": null,
      "question_video": null,
      "map_id": 12000505,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A.</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> <strong>Primaquine</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Primaquine is gametocidal to all species causing malaria. It inhibits transmission of malaria. Artemisinin also have high gametocidal activity against all the species.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Mechanism of Action:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Primaquine interferes with the mitochondrial electron transport chain in the parasite, leading to the death of gametocytes and hypnozoites (dormant liver forms in Plasmodium vivax and Plasmodium ovale).</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">By eliminating gametocytes, primaquine helps reduce the spread of malaria within a community.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Chloroquine:</span></strong><span style=\"font-size:12.0pt\"> is primarily effective against the erythrocytic forms of Plasmodium species but does not have gametocidal activity against all species. It is not effective against the dormant liver forms or the gametocytes of Plasmodium falciparum.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Quinine:</span></strong><span style=\"font-size:12.0pt\"> is effective against the asexual blood stages of Plasmodium species but lacks significant activity against the gametocytes of Plasmodium falciparum. It does not have a broad gametocidal effect against all species.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Primaquine is the antimalarial drug that is gametocidal to all Plasmodium species, making it essential for preventing the transmission of malaria and addressing relapses in cases of Plasmodium vivax and Plasmodium ovale infections.</span></span></span></p>",
      "correct_choice_id": 27676,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 56085,
      "choices": [
        {
          "id": 223765,
          "text": "<p><span style=\"font-size:14pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"color:#434343\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Polyethylene glycol</span></span></span></span></span></p>"
        },
        {
          "id": 223766,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Magnesium citrate</span></span></span></p>"
        },
        {
          "id": 223767,
          "text": "<p><span style=\"font-size:14pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"color:#434343\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Senna</span></span></span></span></span></p>"
        },
        {
          "id": 223768,
          "text": "<p><span style=\"font-size:14pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"color:#434343\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lactulose</span></span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 67-year-old woman presents to the emergency department with severe abdominal pain and vomiting that started 12 hours ago. She has a history of chronic constipation for which she has been using an over-the-counter laxative regularly for the past year. On examination, her abdomen is distended with tenderness on palpation but no signs of guarding or rebound tenderness. Laboratory tests show mild hypokalemia and normal white blood cell count. An abdominal CT scan shows evidence of a thickened colonic wall but no signs of perforation or obstruction. The patient is admitted for further evaluation. During colonoscopy, the mucosa appears darkly pigmented with a brownish-black hue. Which of the following medications is most likely responsible for these findings?</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/06/whatsapp-image-2024-09-06-at-113730-am.jpeg\" style=\"height:276px; width:300px\" /></p>",
      "unique_key": "Q3305367",
      "question_audio": null,
      "question_video": null,
      "map_id": 12000526,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C. Senna</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The clinical findings and colonoscopy appearance described in this case are indicative of melanosis coli, a condition characterized by the pigmentation of the colonic mucosa due to chronic use of stimulant laxatives, such as Senna. Melanosis coli is typically benign and results from the accumulation of apoptotic macrophages in the colonic lamina propria. The pigmentation is usually brownish-black and appears most prominently in the proximal colon. This condition is often associated with long-term use of stimulant laxatives, such as Senna, cascara sagrada, and bisacodyl. Senna is known to stimulate bowel movements by irritating the colonic mucosa, leading to faster transit and decreased water absorption.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Polyethylene glycol:&nbsp;</span></strong><span style=\"font-size:12.0pt\">This is an osmotic laxative that works by retaining water in the stool to soften it and promote bowel movements. It does not have the pigmentary effects associated with stimulant laxatives and is not linked to melanosis coli.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Magnesium citrate:&nbsp;</span></strong><span style=\"font-size:12.0pt\">This is another osmotic laxative that draws water into the intestines, leading to bowel distention and stimulation of peristalsis. It does not cause the pigmentation changes seen in melanosis coli and is not associated with chronic mucosal damage.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Lactulose:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Lactulose is a synthetic disaccharide used to treat constipation and hepatic encephalopathy. It acts as an osmotic laxative but does not cause melanosis coli, as it does not stimulate the bowel mucosa in the same manner as stimulant laxatives.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Melanosis coli is a benign condition characterized by dark pigmentation of the colonic mucosa due to chronic use of stimulant laxatives like Senna. These laxatives should not be used for extended periods due to potential mucosal damage and risk of atonic colon.</span></span></span></p>",
      "correct_choice_id": 223767,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6870,
      "choices": [
        {
          "id": 27448,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ciprofloxacin and tinidazole </span></span></span></p>"
        },
        {
          "id": 27449,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Only ciprofloxacin</span></span></span></p>"
        },
        {
          "id": 27450,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Only ORS</span></span></span></p>"
        },
        {
          "id": 27451,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ciprofloxacin, tinidazole and ORS</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A young male developed 5 episodes of loose stools 2 hours after eating in a restaurant. He is afebrile and has mild dehydration. What should be the treatment? (AIIMS NOV 2017)</span></span></p>",
      "unique_key": "Q4390879",
      "question_audio": null,
      "question_video": null,
      "map_id": 12000527,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C. Only ORS</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Management of diarrhea in an afebrile patient is mainly based on the presence or absence of dehydration. In case of no dehydration or some dehydration, we can manage it using only ORS. If there is severe dehydration, then IV fluids have to be used. There is no role of antibiotics in such case. Empirical antibiotics are used only in case of febrile patients. If only bacterial etiology is suspected, the Ciprofloxacin is used, and it amoebiasis or giardiasis is suspected, then Metronidazole is used.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Ciprofloxacin and tinidazole: </span></strong><span style=\"font-size:12.0pt\">This combination is used for treating bacterial and protozoal infections. However, it is not indicated here because the patient is afebrile and the condition is likely self-limiting.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Only ciprofloxacin: </span></strong><span style=\"font-size:12.0pt\">Ciprofloxacin is an antibiotic used for bacterial infections. Since the patient is afebrile and has mild dehydration, there is no indication for antibiotic therapy. ORS alone is sufficient.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Ciprofloxacin, tinidazole and ORS: </span></strong><span style=\"font-size:12.0pt\">This combination is unnecessary and potentially harmful. Overuse of antibiotics can lead to resistance and other side effects. The primary treatment needed is rehydration with ORS</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">For a young male with afebrile, mild dehydration due to acute diarrhea, the appropriate treatment is oral rehydration solution (ORS) to replace lost fluids and electrolytes. Antibiotics are not indicated unless there is a suspicion of bacterial infection with severe symptoms or fever.</span></span></span></p>",
      "correct_choice_id": 27450,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20908,
      "choices": [
        {
          "id": 83596,
          "text": "<p><span style=\"font-size:12.0pt;\">Clotrimazole</span></p>"
        },
        {
          "id": 83597,
          "text": "<p><span style=\"font-size:12.0pt;\">Griseofulvin</span></p>"
        },
        {
          "id": 83598,
          "text": "<p><span style=\"font-size:12.0pt;\">Terbinafine</span></p>"
        },
        {
          "id": 83599,
          "text": "<p><span style=\"font-size:12.0pt;\">Flucytosine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A bronchial asthma patient who is on inhalational steroids presented with white patchy lesions on the tongue and buccal mucosa. What is the drug that can be used to treat this condition?</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">(NEET PG 2023)</span></p>",
      "unique_key": "Q5226795",
      "question_audio": null,
      "question_video": null,
      "map_id": 12000528,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Clotrimazole</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The given clinical scenario of white patchy lesions on the tongue and buccal mucosa in a patient using inhalational steroids points to diagnosis of oral candidiasis and drug that can be used for the treatment is clotrimazole.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Asthma patients use MDI which can result in deposition of steroids in the oropharyngeal space, which might lead to cough, dysphonia, and oral candidiasis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Clotrimazole is classified under Azole group of Anti-Fungal drugs, acts by inhibiting fungal sterol (ergosterol) synthesis. Used topically in treatment for topical fungal infections like tinea and candida</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/10/picture1.jpg\" alt=\"\" width=\"700\" height=\"289\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Griseofulvin</strong>: Griseofulvin interferes with microtubule function and disrupts mitosis, disrupting the fungal cell division. It is mainly used against dermatophytes and is the drug of choice for tinea capitis in children. But it is not effective against Candida.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C.</strong></span><span style=\"font-size:11pt;\"><strong> </strong></span><span style=\"font-size:12.0pt;\"><strong>Terbinafine</strong>: Terbinafine acts by inhibiting the fungal enzyme squalene epoxidase. which reduces ergosterol biosynthesis. Used to treat nail onychomycosis and other dermatophytosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong></span><span style=\"font-size:14.6667px;\"><strong>&nbsp;</strong></span><span style=\"font-size:12.0pt;\"><strong>Flucytosine</strong></span><span style=\"font-size:12pt;\">: Flucytosine acts by inhibiting nucleic acid synthesis. Used exclusively to combat systemic fungal infections (e.g., cryptococcal meningitis) in combination with amphotericin B.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Clotrimazole is the drug of choice for treating oral candidiasis, especially in patients who develop the condition as a side effect of inhalational steroid use. It works by inhibiting ergosterol synthesis, compromising the fungal cell membrane integrity.</span></p>",
      "correct_choice_id": 83596,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6990,
      "choices": [
        {
          "id": 27928,
          "text": "<p><span style=\"font-size:12.0pt;\">Schedule M drugs</span></p>"
        },
        {
          "id": 27929,
          "text": "<p><span style=\"font-size:12.0pt;\">Schedule H drugs</span></p>"
        },
        {
          "id": 27930,
          "text": "<p><span style=\"font-size:12.0pt;\">Schedule J drugs</span></p>"
        },
        {
          "id": 27931,
          "text": "<p><span style=\"font-size:12.0pt;\">Schedule X drugs</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following drugs should be sold only on prescription from a registered medical practitioner? (AIIMS MAY 2018)</span></p>",
      "unique_key": "Q5233547",
      "question_audio": null,
      "question_video": null,
      "map_id": 12000529,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Schedule H drugs</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Under the \"Drugs and Cosmetics Act,\" certain schedules classify drugs based on various criteria, including the need for prescription, potential for abuse, and manufacturing practices.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Schedule H drugs</strong>: These drugs can only be sold with a prescription from a registered medical practitioner. They are labeled with \"Rx\" written in black color to indicate that they should be dispensed only on prescription.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Schedule M drugs</strong>: These pertain to Good Manufacturing Practices (GMP) for pharmaceuticals and do not indicate a requirement for prescription-based sale.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;C</strong>. <strong>Schedule J drugs</strong>: This schedule lists diseases and ailments for which a drug may not claim to prevent or cure. It does not pertain to prescription requirements.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;D</strong>. <strong>Schedule X drugs</strong>: These are psychotropic substances with a high potential for abuse and must be sold with a valid prescription. While Schedule X drugs also require a prescription, the question specifically asks about drugs that should be sold only on prescription from a registered medical practitioner, making Schedule H drugs the correct answer.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The important schedules under the “Drugs and Cosmetics Act” are:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Schedule H</strong> – The drugs that can be sold only by prescription where Rx is written in black color.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Schedule H1</strong> – for antibiotics where Rx is written in red color.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Schedule G</strong> – Drugs that need labelling as “Dangerous to use except under medical supervision.”</span></li><li><span style=\"font-size:12.0pt;\"><strong>Schedule X</strong> – Psychotropic drugs that have a high abuse liability and are to be sold with a valid prescription only.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Schedule P drug</strong> – describes the life period of drugs in months (unless otherwise specified) between the date of manufacture and date of expiry.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Schedule M</strong> – GMP or Good Manufacturing Practices.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Schedule J </strong>- List of diseases and ailments which a drug may not claim to prevent or cure</span></li></ul>",
      "correct_choice_id": 27929,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "CriteriaBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6521,
      "choices": [
        {
          "id": 26053,
          "text": "<p><span style=\"font-size:12.0pt;\">Metformin</span></p>"
        },
        {
          "id": 26054,
          "text": "<p><span style=\"font-size:12.0pt;\">Methysergide</span></p>"
        },
        {
          "id": 26055,
          "text": "<p><span style=\"font-size:12.0pt;\">Bleomycin</span></p>"
        },
        {
          "id": 26056,
          "text": "<p><span style=\"font-size:12.0pt;\">Nitrofurantoin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following drugs is not likely to cause a pleural pathology? (NEET PG 2022)</span></p>",
      "unique_key": "Q9157054",
      "question_audio": null,
      "question_video": null,
      "map_id": 12000530,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Metformin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Metformin is an oral hypoglycemic agent used primarily in the treatment of type 2 diabetes mellitus. It works by decreasing hepatic glucose production and increasing insulin sensitivity. Metformin is not associated with pleural pathologies, making it the correct choice in this context.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Methysergide</strong>: Methysergide is a medication used to prevent migraine headaches and is known for its potential to cause retroperitoneal and pleural fibrosis. This pleural pathology is a serious adverse effect, although the drug is not commonly used today due to this risk.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Bleomycin</strong>: Bleomycin is a chemotherapeutic agent used in the treatment of various cancers. One of its well-known side effects is pulmonary toxicity, which can manifest as pulmonary fibrosis. Pleural involvement, including pleural effusions and fibrosis, can occur secondary to its pulmonary effects.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Nitrofurantoin</strong>: Nitrofurantoin is an antibiotic used primarily for urinary tract infections. It can cause pulmonary reactions, including acute, subacute, and chronic pulmonary reactions. These reactions can involve the pleura, leading to pleural effusions and other pleural pathologies.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Metformin is not associated with causing pleural pathologies, unlike Methysergide, Bleomycin, and Nitrofurantoin, which have known risks of causing pleural and pulmonary complications.</span></p>",
      "correct_choice_id": 26053,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24709,
      "choices": [
        {
          "id": 98797,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Lapatinib</span></span></span></p>"
        },
        {
          "id": 98798,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Sorafenib</span></span></span></p>"
        },
        {
          "id": 98799,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Vismodegib</span></span></span></p>"
        },
        {
          "id": 98800,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Erlotinib</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 60-year-old female is diagnosed with breast cancer. Her tumor is found to be HER2-positive but estrogen receptor (ER) and progesterone receptor (PR) negative. The tumor was resistant to trastuzumab.<strong> </strong>Which of the following drugs is most likely to be effective in the treatment of this patient&#39;s breast cancer?</span></span>(INICET MAY 2023)</p>",
      "unique_key": "Q3073463",
      "question_audio": null,
      "question_video": null,
      "map_id": 12000531,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A. Lapatinib</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Lapatinib is a tyrosine kinase inhibitor that can be used for the treatment of HER2-positive but trastuzumab-resistant breast cancer. Trastuzumab is a monoclonal antibody that is commonly used for the treatment of HER2-positive breast cancer, but some patients may develop resistance to this drug over time. Lapatinib works by targeting the HER2 receptor, which is overexpressed in HER2-positive breast cancer, and can be effective in treating breast cancer that has become resistant to trastuzumab. </span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B.</span></strong><span style=\"font-size:12.0pt\"> Sorafenib is a kinase inhibitor that is primarily used for the treatment of advanced liver cancer and kidney cancer. It works by blocking the activity of several proteins that promote the growth and spread of cancer cells.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C.</span></strong><span style=\"font-size:12.0pt\"> Vismodegib is a hedgehog pathway inhibitor that is used for the treatment of basal cell carcinoma, a type of skin cancer. It works by blocking the hedgehog signalling pathway, which is involved in the development and growth of cancer cells.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D.</span></strong><span style=\"font-size:12.0pt\"> Erlotinib is a tyrosine kinase inhibitor that is used for the treatment of non-small cell lung cancer, pancreatic cancer, and other types of cancer. It works by blocking the activity of the epidermal growth factor receptor (EGFR), which is involved in the growth and spread of cancer cells.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Lapatinib is an effective treatment for HER2-positive breast cancer, especially in cases where the cancer has become resistant to trastuzumab. It works by targeting the HER2 receptor and can help manage this specific type of breast cancer.</span></span></span></p>",
      "correct_choice_id": 98797,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6967,
      "choices": [
        {
          "id": 27836,
          "text": "<p><span style=\"font-size:12pt;\">Prednisolone</span></p>"
        },
        {
          "id": 27837,
          "text": "<p><span style=\"font-size:12pt;\">Salbutamol</span></p>"
        },
        {
          "id": 27838,
          "text": "<p><span style=\"font-size:12pt;\">Fexofenadine</span></p>"
        },
        {
          "id": 27839,
          "text": "<p><span style=\"font-size:12pt;\">Amoxicillin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">A known asthmatic patient with fever and sore throat was prescribed an antibiotic. Two days later he presents with a maculopapular rash. Which of the following drugs might have caused this? (INICET NOV 2020)</span></p>",
      "unique_key": "Q5605965",
      "question_audio": null,
      "question_video": null,
      "map_id": 12015635,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D. Amoxicillin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Out of the options given above, amoxicillin is the only drug which is an antibiotic. It is an amino penicillin. Allergic reactions in the form of skin rashes to Penicillin group of antibiotics are very common, out of which it is the highest with aminopenicillins.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Options A.</strong>&nbsp;<strong>Prednisolone</strong>: This is a corticosteroid used in the treatment of asthma to reduce inflammation. Corticosteroids like prednisolone are not typically associated with causing maculopapular rashes. In fact, they are often used to treat allergic reactions and rashes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Options B.</strong>&nbsp;<strong>Salbutamol</strong>: Also known as albuterol, this is a bronchodilator used to relieve bronchospasm in conditions like asthma. Salbutamol is not commonly associated with skin rashes like a maculopapular rash.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Options C.</strong>&nbsp;<strong>Fexofenadine</strong>: This is an antihistamine used for allergic reactions. It is unlikely to cause a maculopapular rash and is more commonly used to treat such rashes when they are due to allergic reactions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Amoxicillin, an aminopenicillin antibiotic, is commonly associated with allergic reactions, including maculopapular rashes. This is a well-known side effect of penicillin antibiotics. Prednisolone, salbutamol, and fexofenadine are less likely to cause such reactions, and in the case of prednisolone and fexofenadine, they are actually used to treat allergic reactions and rashes.</span></p>",
      "correct_choice_id": 27839,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20862,
      "choices": [
        {
          "id": 83412,
          "text": "<p><span style=\"font-size:12pt;\">Dermoid cyst</span></p>"
        },
        {
          "id": 83413,
          "text": "<p><span style=\"font-size:12pt;\">Parotid tumor</span></p>"
        },
        {
          "id": 83414,
          "text": "<p><span style=\"font-size:12pt;\">Sebaceous cyst</span></p>"
        },
        {
          "id": 83415,
          "text": "<p><span style=\"font-size:12pt;\">Cervical lymph node</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 40-year-old male patient presented in OPD with a swelling that has been slowly growing in the past 2 years. On examination, it was variable in consistency and mobile. What is the most likely diagnosis?&nbsp;(NEET PG 2023)</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/08/picture27_GCmFIMc.jpg\" alt=\"\" width=\"300\" height=\"221\"></span></p>",
      "unique_key": "Q9867988",
      "question_audio": null,
      "question_video": null,
      "map_id": 12015636,
      "difficulty_level": "beginner",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Parotid tumor</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">The given clinical scenario and image points to a diagnosis of parotid tumor.</span></li><li><span style=\"font-size:12pt;\">MC benign parotid tumor is Pleomorphic Adenoma.</span></li><li><span style=\"font-size:12pt;\">MC site: superficial lobe of parotid</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/31/pathogenesis_page_3.jpg\" alt=\"\" width=\"1000\" height=\"1276\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Dermoid cyst:&nbsp;</strong>Seen in children at lines of mesodermal fusion like outer canthus of eye.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/31/picture29.jpg\" alt=\"\" width=\"300\" height=\"233\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Sebaceous cyst:&nbsp;</strong>Will show soft consistency and punctum.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/31/picture30.jpg\" alt=\"\" width=\"300\" height=\"284\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Swollen cervical lymph node</strong> – will show firm consistency.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/31/picture31.jpg\" alt=\"\" width=\"300\" height=\"301\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">A parotid tumor, particularly pleomorphic adenoma, is the most common benign tumor of the parotid gland.</span></li><li><span style=\"font-size:12pt;\">It is characterized by slow growth, a variable consistency, and mobility, commonly found in the superficial lobe of the parotid gland.</span></li><li><span style=\"font-size:12pt;\">Proper diagnosis involves imaging and FNAC, with treatment typically involving surgical removal while preserving the facial nerve if possible.</span></li></ul>",
      "correct_choice_id": 83413,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14060,
      "choices": [
        {
          "id": 56201,
          "text": "<p><span style=\"font-size:12.0pt;\">Intubate</span></p>"
        },
        {
          "id": 56202,
          "text": "<p><span style=\"font-size:12.0pt;\">Insert needle in appropriate intercostal space</span></p>"
        },
        {
          "id": 56203,
          "text": "<p><span style=\"font-size:12.0pt;\">Start intravenous fluids urgently</span></p>"
        },
        {
          "id": 56204,
          "text": "<p><span style=\"font-size:12.0pt;\">Take a chest X-ray</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient was brought to the casualty after an RTA. He has suffered chest trauma, has respiratory rate of 44/min and BP is 90/40 mm of hg. He is conscious and speaks single words. There is a hyper-resonance on percussion on the involved side of his chest. What will be your immediate next step? (AIIMS NOV 2018)</span></p>",
      "unique_key": "Q3335435",
      "question_audio": null,
      "question_video": null,
      "map_id": 12015637,
      "difficulty_level": "beginner",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Insert needle in appropriate intercoastal space</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The given clinical scenario of hemodynamic instability and hyper-resonance on the affected side is suggestive of tension pneumothorax.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The next immediate step of management is inserting a needle i.e. needle decompression in the appropriate intercostal space (ICS).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The presence of hyper-resonance on percussion and the patient's signs of respiratory distress suggest a potential tension pneumothorax. A tension pneumothorax occurs when air accumulates in the pleural space and compresses the lung, leading to severe respiratory compromise. Inserting a needle (needle decompression) in the appropriate intercostal space is a life-saving procedure to release the trapped air and relieve the pressure on the affected lung.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A</strong>. <strong>Intubate</strong>: While maintaining a patient's airway is crucial in cases of respiratory distress, intubation is not the immediate next step in this case. The patient is conscious and speaking, indicating that they have a patent airway. The primary concern is addressing the chest trauma and potential tension pneumothorax.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Start intravenous fluids</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>urgently</strong>: While providing intravenous fluids may be necessary, it is not the immediate priority in this case.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Take a chest X-ray</strong>: While a chest X-ray can provide valuable diagnostic information, it is not the immediate next step in a suspected tension pneumothorax. Clinical signs and symptoms, including chest percussion and the patient's condition, warrant immediate intervention to relieve the pressure on the lung.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Management of tension pneumothorax:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Immediate management: Needle decompression or needle thoracostomy i.e. insertion of a wide-bore needle in the 5th ICS anterior to the midaxillary line</span></li><li><span style=\"font-size:12.0pt;\">Definitive management: Tube thoracostomy or chest tube insertion in the 5th ICS in the triangle of safety</span></li><li><span style=\"font-size:12.0pt;\">Note: According to ATLS 10th edition</span></li><li><span style=\"font-size:12.0pt;\">In adults, needle thoracostomy or needle decompression location is changed to 5th ICS anterior to the midaxillary line from 2nd ICS midclavicular line.</span></li><li><span style=\"font-size:12.0pt;\">However, In the pediatric age group, the needle thoracostomy location remains at the 2nd ICS midclavicular line.</span></li></ul>",
      "correct_choice_id": 56202,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20874,
      "choices": [
        {
          "id": 83460,
          "text": "<p><span style=\"font-size:12pt;\">C2</span></p>"
        },
        {
          "id": 83461,
          "text": "<p><span style=\"font-size:12pt;\">C3</span></p>"
        },
        {
          "id": 83462,
          "text": "<p><span style=\"font-size:12pt;\">C4a</span></p>"
        },
        {
          "id": 83463,
          "text": "<p><span style=\"font-size:12pt;\">C4b</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">A patient is diagnosed with varicose veins comes to OPD with complaints of eczema over the same region. What is the stage of the clinical classification according to the CEAP guidelines?&nbsp;</span><span style=\"font-size:12.0pt;\">(NEET PG 2023)</span></p>",
      "unique_key": "Q9313662",
      "question_audio": null,
      "question_video": null,
      "map_id": 12015638,
      "difficulty_level": "beginner",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) C4a</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">The descriptive CEAP (Clinical-Etiology-Anatomy-Pathophysiology) classification for chronic venous disorders is as follows:</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/31/pathogenesis_page_8.jpg\" alt=\"\" width=\"1000\" height=\"1189\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. C2:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Description:</strong> Varicose veins without any additional skin changes or complications.</span></li><li><span style=\"font-size:12pt;\"><strong>Why Incorrect:</strong> The patient has eczema, which indicates a more advanced stage than C2.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. C3:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Description:</strong> Presence of oedema without skin changes.</span></li><li><span style=\"font-size:12pt;\"><strong>Why Incorrect:</strong> The patient has eczema, not just oedema.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. C4b:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Description:</strong> Lipodermatosclerosis or atrophie blanche.</span></li><li><span style=\"font-size:12pt;\"><strong>Why Incorrect:</strong> The patient has eczema, which is classified under C4a, not the more severe skin changes seen in C4b.</span></li></ul><h3>&nbsp;</h3><h3><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></h3><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">According to the CEAP classification for chronic venous disorders, the presence of eczema or pigmentation in a patient with varicose veins is classified as stage C4a.</span></li></ul>",
      "correct_choice_id": 83462,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "CriteriaBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7031,
      "choices": [
        {
          "id": 28092,
          "text": "<p><span style=\"color:#333333;font-size:12pt;\">Sialorrhea</span></p>"
        },
        {
          "id": 28093,
          "text": "<p><span style=\"color:#333333;font-size:12pt;\">Anorgasmia</span></p>"
        },
        {
          "id": 28094,
          "text": "<p><span style=\"color:#333333;font-size:12pt;\">Nausea</span></p>"
        },
        {
          "id": 28095,
          "text": "<p><span style=\"color:#333333;font-size:12pt;\">Vivid dreams</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"color:#333333;font-size:12pt;\">A bank employee, felt depressed with no interest in activities, came to AIIMS OPD. He was started on escitalopram. Which of these adverse effects cannot be explained with escitalopram? (AIIMS MAY 2019)</span></p>",
      "unique_key": "Q1752586",
      "question_audio": null,
      "question_video": null,
      "map_id": 12015639,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"color:#333333;font-size:12pt;\"><strong>Ans.&nbsp;A. Sialorrhea</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Sialorrhea, or excessive saliva production, is not a common side effect of SSRIs like escitalopram. It is more commonly associated with the atypical antipsychotic drug clozapine.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Anorgasmia:&nbsp;</strong>Anorgasmia, or difficulty achieving orgasm, is a well-known side effect of SSRIs due to their impact on serotonin levels, which can interfere with sexual function.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Nausea:&nbsp;</strong>Nausea is one of the most common side effects of SSRIs. It typically occurs at the beginning of treatment and may subside with continued use.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Vivid dreams:&nbsp;</strong>Vivid dreams are another common side effect of SSRIs. They occur due to the influence of increased serotonin levels on sleep patterns.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"color:#333333;font-size:12pt;\">Escitalopram is a Selective Serotonin Reuptake Inhibitor (SSRI).</span></li><li><span style=\"color:#333333;font-size:12pt;\">Other SSRIs include Fluoxetine, Paroxetine, Fluvoxamine etc.</span></li><li><span style=\"color:#333333;font-size:12pt;\">Side-effects of SSRI include:</span></li><li><span style=\"color:#333333;font-size:12pt;\">Most common: Nausea, Vomiting</span></li><li><span style=\"color:#333333;font-size:12pt;\">Next most common: Anxiety etc.</span></li><li><span style=\"color:#333333;font-size:12pt;\">Other side effects- Delayed ejaculation, anorgasmia, diarrhea, vivid dreams etc.</span></li><li><span style=\"color:#333333;font-size:12pt;\">Main drug which causes sialorrhea is CLOZAPINE (an atypical anti-psychotic drug)</span></li></ul><p>&nbsp;</p><p><span style=\"color:#333333;font-size:12pt;\"><strong>Reference: - KDT 8<sup>TH</sup>/488</strong></span></p>",
      "correct_choice_id": 28092,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}